Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,19729,64,1.17 [0.30-4.64],0.822905794325166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,19200,61,1.18 [0.75-1.85],0.4753075595390653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,22521,70,1.25 [0.86-1.80],0.2401316851588967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,19099,60,1.54 [0.87-2.74],0.1395337873608408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,22390,64,1.09 [0.75-1.60],0.6494418302702726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,22521,70,1.16 [0.86-1.57],0.3286563016865699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,19703,63,1.10 [0.94-1.30],0.2445393691808731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,19099,60,0.94 [0.64-1.38],0.7548855544156093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22112,69,1.38 [1.10-1.74],0.0051624414614969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19320,61,0.98 [0.69-1.38],0.8886140898190364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19699,63,0.96 [0.73-1.26],0.7682063886904836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,22422,72,1.62 [0.77-3.42],0.2048298224241357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,19703,63,1.22 [0.48-3.05],0.6780697148679057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22222,70,2.21 [1.68-2.91],1.862805691874763e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,19288,62,1.74 [0.93-3.24],0.0829194796111607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,19597,60,0.98 [0.79-1.22],0.8714804224760476
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22626,72,1.13 [0.77-1.67],0.5263098324084452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,19152,63,1.48 [0.94-2.32],0.0889475950125899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,22733,71,1.62 [0.93-2.82],0.0868627466802001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,22786,71,1.39 [0.98-1.98],0.067968738091097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,19591,60,1.34 [0.73-2.46],0.3379734486555257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,19152,63,0.93 [0.47-1.86],0.840911934884315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,19099,60,1.03 [0.54-1.96],0.9226692257314602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22222,70,1.03 [0.63-1.67],0.909343760761176
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,19099,60,0.94 [0.59-1.50],0.7938905505449486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,22198,70,1.05 [0.55-2.00],0.8786402195702046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,22435,65,1.24 [0.51-3.04],0.636625808838015
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,22626,72,1.47 [1.08-2.01],0.0142311845093529
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19099,60,1.56 [1.05-2.34],0.0293898319628114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,19205,62,1.13 [0.79-1.63],0.5089085375603886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,22873,71,1.96 [1.19-3.25],0.0087057021552433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,22466,69,1.86 [1.16-2.96],0.009346605877166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19152,63,1.56 [0.93-2.62],0.0951228089388251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22222,70,2.20 [1.11-4.35],0.0241478714021967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22470,65,1.58 [0.84-2.96],0.1548340368263012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22873,71,0.93 [0.52-1.67],0.8115344978800502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22781,68,0.98 [0.45-2.12],0.9641805410125406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19597,60,1.97 [0.96-4.04],0.0639158333867683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19152,63,0.90 [0.41-2.00],0.7988439633374628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22897,73,0.84 [0.35-2.05],0.7086672560289541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22521,70,1.22 [0.74-2.01],0.4313829573935275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22222,70,0.98 [0.49-1.95],0.9569166159515252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19152,63,0.65 [0.31-1.33],0.2361301698445787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22695,72,1.01 [0.63-1.61],0.9790475296701528
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,19695,63,2.63 [1.39-4.97],0.0029432888364207
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,19200,61,0.60 [0.21-1.77],0.3577185571491263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,19699,63,1.66 [0.92-2.99],0.0893880667026143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22112,69,1.24 [0.85-1.82],0.2576312716840803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,19288,62,1.16 [0.82-1.64],0.3969498539196545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,22435,65,2.14 [1.16-3.95],0.014384684466526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19288,62,4.06 [2.34-7.02],5.877561195905196e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,19597,60,1.85 [1.25-2.74],0.0019720587854183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,22729,72,2.63 [1.31-5.29],0.0067141882800072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,22789,72,2.42 [1.43-4.08],0.0009743612862702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,19699,63,1.64 [0.72-3.70],0.236424897168532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,22521,70,1.67 [1.34-2.08],5.118555476996801e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,22626,72,1.23 [0.56-2.68],0.6059579669899038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,19090,59,0.68 [0.43-1.06],0.0906153373264852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,19288,62,1.33 [1.00-1.76],0.0464752911982436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22222,70,1.17 [0.92-1.49],0.2097427639979339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,19729,64,0.94 [0.66-1.34],0.7446356256435438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,22825,71,1.25 [0.55-2.85],0.5932173732201823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,19099,60,1.16 [0.87-1.56],0.3149427256880348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,19288,62,0.96 [0.72-1.29],0.789259265785099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFM,Afamin,19729,64,0.81 [0.23-2.79],0.732808695034628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,22408,65,1.15 [0.83-1.58],0.4056271583461851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,19090,59,0.93 [0.71-1.21],0.5976997433585016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,22577,72,1.68 [1.02-2.78],0.0425328187263629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,21863,66,1.04 [0.84-1.28],0.7438842353874681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,22072,69,0.98 [0.68-1.40],0.8985563167614115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,22729,72,1.61 [0.90-2.90],0.1099326350704918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,22873,71,1.71 [1.14-2.57],0.0092538994001279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,19703,63,0.77 [0.34-1.76],0.5315905681568581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,22626,72,1.46 [1.16-1.85],0.0013227096989307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,22626,72,1.21 [0.90-1.63],0.215643920357421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,19200,61,1.50 [0.74-3.01],0.2586831554362611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,19200,61,1.48 [0.67-3.28],0.329056833621242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19591,60,0.95 [0.65-1.39],0.7993606550992731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,19703,63,1.26 [0.51-3.11],0.6106461464796609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,22595,68,1.16 [0.91-1.47],0.230438004552739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",19152,61,0.86 [0.62-1.20],0.3814114015773122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,22112,69,1.04 [0.69-1.57],0.8393515816409947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,19200,61,1.01 [0.66-1.54],0.9552301891584126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22476,70,1.11 [0.91-1.35],0.3077605298656456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,22626,72,1.19 [0.87-1.61],0.2775753801087723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",19658,61,1.11 [0.88-1.40],0.3590379105034047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,19288,62,0.95 [0.30-3.00],0.9315459349178298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,22112,69,1.02 [0.77-1.34],0.915530962144241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,19152,61,1.20 [0.85-1.70],0.2903093920773029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,22222,70,1.08 [0.76-1.54],0.6737168515402814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,19152,63,1.55 [1.23-1.97],0.0002440244388985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,22060,66,1.21 [0.87-1.68],0.2575533670641048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,19667,61,1.08 [0.89-1.32],0.4308944819850352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,22002,67,0.96 [0.65-1.41],0.8365205572574358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,22897,73,8.70 [3.43-22.05],5.125912813936201e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,22630,68,1.50 [1.08-2.09],0.0167340775065758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",19591,60,1.28 [0.90-1.81],0.1635095642622852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22552,70,1.17 [0.90-1.52],0.242088295541694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19667,61,1.57 [1.03-2.39],0.0369346907097588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,19320,61,0.75 [0.40-1.39],0.3597437906318004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,19152,63,0.99 [0.81-1.21],0.9448997339973072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",22521,70,1.25 [1.02-1.54],0.0312322597284153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,22198,70,0.97 [0.45-2.12],0.94383025322344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,22792,71,1.10 [0.38-3.18],0.8533050705915854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19695,63,0.86 [0.34-2.19],0.7540556753960022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,22060,66,0.88 [0.61-1.27],0.4996642395317332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,19152,61,0.94 [0.56-1.57],0.8114339708142726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,22521,70,1.41 [0.55-3.61],0.4683789874395784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,22198,70,0.55 [0.35-0.88],0.0129948827693719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19288,62,2.67 [1.64-4.35],8.146536151217524e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,19532,59,1.04 [0.63-1.72],0.8655741176965291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,19658,61,0.95 [0.68-1.33],0.7648737652073216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18436,62,0.84 [0.50-1.40],0.5056554879361144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,21726,68,1.18 [0.75-1.86],0.4688682763279539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,21071,66,1.13 [0.72-1.79],0.5990231880270002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,22540,69,0.84 [0.45-1.59],0.595233382649347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,22547,72,0.96 [0.75-1.22],0.7412722089578746
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,22825,71,1.71 [1.01-2.90],0.0451411176773136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22321,71,2.19 [1.08-4.44],0.0292550532016151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,22662,72,1.61 [0.98-2.67],0.0625794456815941
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,22609,70,0.90 [0.50-1.62],0.737822880219899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,22690,72,1.78 [1.12-2.83],0.0154702651809055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,22825,71,2.14 [1.30-3.54],0.0029253895576906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,19099,60,0.96 [0.67-1.35],0.796249671828499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19152,63,1.38 [1.03-1.84],0.0329089858827554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,19005,60,0.80 [0.50-1.28],0.3492715650205825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,22112,69,1.06 [0.74-1.51],0.7651448303214249
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19200,61,1.25 [0.79-1.97],0.335231077397338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,22646,71,2.95 [1.68-5.17],0.0001671878521012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,19162,61,1.26 [0.78-2.01],0.3429589070191016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,22060,66,1.24 [0.98-1.57],0.0713144757634796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,22555,70,1.00 [0.73-1.36],0.9890208784207072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,18907,59,0.92 [0.64-1.33],0.651828121169087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,22781,68,1.00 [0.74-1.36],0.981973429740298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,22510,72,1.14 [0.86-1.52],0.3496852281849402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,21999,65,0.90 [0.43-1.90],0.7870529273126269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],22198,70,0.77 [0.49-1.21],0.2546272552708347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,22687,71,1.75 [0.87-3.49],0.1142287901803104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,19591,60,1.07 [0.79-1.45],0.661252639802276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,19152,61,0.74 [0.42-1.29],0.2912807165969943
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,19597,60,1.18 [0.86-1.62],0.3019022980265946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,19658,61,1.26 [0.77-2.06],0.3554631839316992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22521,70,0.90 [0.55-1.48],0.6767551214821421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,19547,63,0.43 [0.23-0.80],0.0072903590968556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22752,71,1.04 [0.73-1.47],0.8270164000631275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,22626,72,1.30 [0.88-1.92],0.1914507283382578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,19729,64,0.58 [0.22-1.55],0.2785698875240581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,19703,63,1.34 [0.83-2.17],0.2294676783417942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,19729,64,0.66 [0.32-1.37],0.269053813940161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,19703,63,0.79 [0.28-2.21],0.6549117544121668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,19200,61,1.38 [0.75-2.53],0.3049252210456681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,19685,64,0.91 [0.46-1.81],0.7897517973113838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,18815,60,0.48 [0.22-1.05],0.0679095928750881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,19729,64,1.13 [0.86-1.48],0.37047176306783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,19703,63,0.63 [0.34-1.16],0.1402126776277165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,22630,68,1.01 [0.55-1.85],0.9698102032689352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,19703,63,0.67 [0.43-1.06],0.0841349532481083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,22649,70,0.53 [0.25-1.15],0.1096810712922873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,22596,68,0.86 [0.62-1.19],0.3625066839182902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,19288,62,1.08 [0.86-1.34],0.5154268559931796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,22440,65,1.18 [0.74-1.89],0.4892015415475832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,19320,61,1.11 [0.79-1.55],0.5560940320010035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,22521,70,1.57 [1.06-2.34],0.025269066470203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,19597,60,1.16 [0.92-1.48],0.2141523588210142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,19667,61,1.08 [0.76-1.54],0.6591073043385868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,22530,71,1.15 [0.77-1.69],0.4953116986035631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",19591,60,0.70 [0.37-1.35],0.2926749017462809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,22112,69,1.19 [0.74-1.91],0.4685170990256979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,22112,69,1.13 [0.79-1.60],0.5028176736549737
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,19320,61,0.75 [0.35-1.62],0.4665712926015803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,19288,62,1.23 [0.92-1.66],0.1672395068610754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,19005,60,0.92 [0.66-1.28],0.6174203780429965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,19658,61,1.19 [0.91-1.57],0.2041402276230371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,19667,61,1.10 [0.85-1.43],0.4634123714148598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,22585,70,1.03 [0.84-1.27],0.7597806984326708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,19090,59,1.11 [0.81-1.52],0.5321102498041901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,19090,59,0.93 [0.49-1.76],0.8133805884891392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,22060,66,1.24 [0.84-1.84],0.2867246689326395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,19099,60,1.15 [0.83-1.60],0.4113114329680013
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19099,60,1.55 [0.88-2.75],0.1318749777614246
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,19090,59,0.98 [0.66-1.45],0.9078904970850166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,22198,70,1.12 [0.65-1.94],0.6811316871323461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19099,60,0.78 [0.44-1.37],0.3781930167444436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,22630,68,0.99 [0.61-1.61],0.9668100911812024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,22521,70,0.93 [0.63-1.38],0.7302347391268933
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,22687,71,1.06 [0.56-1.99],0.8607001581355126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,19090,59,1.08 [0.77-1.51],0.6683572542461003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,22198,70,0.66 [0.36-1.20],0.1733870593407238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,19512,63,1.22 [0.77-1.94],0.3929439298328029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,22470,65,1.14 [0.73-1.78],0.5676486387850084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,22470,65,1.92 [0.94-3.92],0.0716389067937601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,19703,63,1.00 [0.40-2.51],0.9954019258012344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,19699,63,2.22 [1.29-3.82],0.0038243960747356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,19667,61,1.17 [0.82-1.68],0.3853937301410683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,19200,61,1.14 [0.90-1.45],0.2793624215534484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,19099,60,1.35 [1.01-1.81],0.0448445658701093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,22060,66,0.87 [0.59-1.27],0.4710212817607966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,19005,60,0.66 [0.29-1.47],0.3065034266143768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,19597,60,1.07 [0.80-1.44],0.6474808000641722
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,22112,69,1.21 [0.86-1.71],0.2747270692187935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,22695,72,1.25 [0.92-1.70],0.1487496116415042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19099,60,1.16 [0.77-1.75],0.4843227958380306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19099,60,1.20 [0.58-2.46],0.6208579537249742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19099,60,1.07 [0.60-1.90],0.8309963208196673
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,19005,60,0.85 [0.45-1.59],0.6091793605131927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,19099,60,1.18 [0.85-1.65],0.3153756400142535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",19099,60,1.27 [0.92-1.73],0.1433855799473253
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",22729,72,1.01 [0.84-1.22],0.8962729819414446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",22060,66,0.85 [0.49-1.48],0.5701505247944401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,22112,69,0.97 [0.57-1.65],0.9080554330646248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,22521,70,0.49 [0.20-1.19],0.1148159149877373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,22011,65,0.86 [0.61-1.22],0.3951190235992252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,19200,61,1.06 [0.76-1.49],0.7297144575353032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,19099,60,1.05 [0.83-1.34],0.6638164729775207
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,19597,60,1.08 [0.49-2.38],0.8452332180565914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",19729,64,0.96 [0.23-4.02],0.9556298846401342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,22060,66,0.99 [0.73-1.34],0.9472766902537318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,19090,59,0.96 [0.76-1.21],0.7247154291116358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,19667,61,1.32 [0.85-2.06],0.2193032844031214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,19658,61,1.02 [0.69-1.51],0.9142798005448568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,22585,70,1.10 [0.88-1.37],0.424169682446451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,22687,71,1.91 [0.93-3.92],0.0771211634682366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,19667,61,1.26 [0.83-1.91],0.2714268745122033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,21902,66,1.12 [0.86-1.45],0.3963017455406643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,19729,64,0.71 [0.30-1.70],0.4444354460022269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19099,60,0.61 [0.17-2.23],0.4570821295736611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19200,61,1.80 [0.91-3.57],0.0892477782766919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",22729,72,2.01 [0.96-4.23],0.0643885686520709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",22630,68,0.79 [0.32-1.94],0.6055170158429481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,19152,63,1.52 [0.85-2.71],0.1533592129799332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,22585,70,1.16 [0.87-1.54],0.3081962594932431
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,22435,65,0.94 [0.54-1.61],0.8113027097619853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,19152,63,1.33 [0.85-2.06],0.2088473235090311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,22222,70,1.20 [0.66-2.16],0.5482165015575486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22112,69,1.57 [1.21-2.04],0.000765065608902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,22112,69,1.30 [0.64-2.62],0.4640725830733165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,22585,70,1.13 [0.92-1.39],0.2431047377589332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,19658,61,0.94 [0.65-1.36],0.7397850873770814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,19152,61,1.20 [0.98-1.49],0.0820356468834016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,22030,66,1.22 [0.96-1.56],0.108993268837464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,22630,68,3.99 [2.14-7.46],1.4245003363450216e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,22470,65,1.09 [0.57-2.09],0.7838010529883963
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19699,63,1.72 [0.89-3.30],0.1041078437982085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19090,59,0.46 [0.24-0.89],0.0206909008583974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,19330,62,0.58 [0.34-0.99],0.0443347618256397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,19597,60,1.25 [0.87-1.78],0.2231852589238327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,19658,61,1.11 [0.86-1.42],0.4263372433191114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22585,70,1.07 [0.66-1.74],0.7686474219977484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,19152,63,0.78 [0.49-1.25],0.2997218163525548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,19005,60,1.14 [0.80-1.60],0.4708198996528718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,19591,60,1.37 [0.90-2.10],0.1427163813499189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,22585,70,1.07 [0.85-1.35],0.5748058703520493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,19695,63,0.85 [0.64-1.12],0.2499449771348968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,19200,61,1.22 [0.83-1.79],0.3034759452661659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,19005,60,1.25 [0.82-1.89],0.3003668295489949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,19695,63,1.36 [1.03-1.80],0.02853818981114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,22073,69,1.12 [0.94-1.33],0.1887038549881969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,19090,59,0.95 [0.66-1.36],0.7841275510572212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19099,60,0.69 [0.26-1.82],0.4534319247927605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,22585,70,1.13 [0.84-1.53],0.4194086731849384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,22630,68,1.08 [0.85-1.36],0.5196219667019407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,22112,69,1.08 [0.77-1.51],0.6720389793161893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,22897,73,1.10 [0.58-2.08],0.7649376258228126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,19152,63,0.76 [0.37-1.55],0.4493662725926233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19090,59,0.96 [0.68-1.36],0.8313227559836206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19658,61,1.23 [0.68-2.21],0.4928599195234511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,22630,68,1.18 [0.88-1.59],0.2741414640346652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19288,62,1.16 [0.49-2.74],0.7403634022340049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,22435,65,1.69 [1.10-2.58],0.0157710625614481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,22186,70,1.16 [0.69-1.93],0.578144554610279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,19288,62,3.65 [2.00-6.67],2.5801099526866097e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19699,63,1.21 [0.61-2.41],0.5795088524849024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19152,63,1.28 [0.77-2.14],0.3375866894302162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,22222,70,1.84 [0.75-4.52],0.1843492059608054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,19090,59,1.13 [0.73-1.73],0.5871204263257843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,19200,61,1.09 [0.70-1.69],0.7114425825743469
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,18518,59,0.98 [0.78-1.24],0.8716828319780079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,22568,72,0.91 [0.65-1.27],0.5757651657768682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,19665,63,1.18 [0.86-1.62],0.3039621820393128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,19427,60,1.07 [0.85-1.35],0.5532307293631216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,19320,61,0.78 [0.33-1.84],0.5689959639773934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,19090,59,0.69 [0.30-1.60],0.390698325578478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,19099,60,0.80 [0.44-1.46],0.4667405146478565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,19099,60,1.62 [0.90-2.93],0.1090750760911683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,22060,66,0.76 [0.46-1.26],0.2812213635568585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,19090,59,1.08 [0.64-1.81],0.7719769227328358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,19667,61,1.24 [0.71-2.17],0.4442569426346161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSG,Basigin,22833,71,1.70 [0.59-4.91],0.3308185555468759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BSND,Barttin,19005,60,1.18 [0.60-2.32],0.634851581651904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22821,68,0.86 [0.58-1.29],0.4776114031708734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,22821,68,1.91 [1.50-2.43],1.7978951224518946e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,22112,69,0.96 [0.72-1.29],0.7914266876011533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,19729,64,1.24 [0.39-3.96],0.7112427677754358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,19005,60,1.32 [1.13-1.55],0.0005192558832167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,19555,59,0.92 [0.49-1.76],0.8121207634315635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,22729,72,1.58 [0.72-3.46],0.2557626950878458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,22585,70,1.76 [1.10-2.82],0.0183261709493211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,19005,60,1.02 [0.57-1.83],0.956176718230597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,22060,66,1.23 [0.93-1.62],0.1417082360041069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,19099,60,2.36 [1.52-3.67],0.0001311966140723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,22756,71,2.11 [0.86-5.22],0.1047516541146462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19667,61,0.75 [0.46-1.21],0.2399773351081598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,19152,63,0.97 [0.56-1.68],0.9112702294937104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22687,71,1.78 [1.18-2.69],0.0057767472385614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19288,62,2.33 [1.22-4.46],0.0104411160608218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19667,61,1.25 [0.64-2.44],0.5224540569112133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19245,61,1.76 [1.00-3.09],0.0486813665090271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,19729,64,0.65 [0.29-1.44],0.2869471837673668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,19697,64,0.55 [0.27-1.13],0.1038458519728032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,19729,64,0.66 [0.33-1.30],0.2296770388744438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2,Complement C2,22649,70,1.40 [0.52-3.75],0.5044350049084306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,22011,65,1.28 [0.82-1.99],0.2756442178962778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,19152,61,1.06 [0.71-1.58],0.766604446694479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C3,Complement C3,18721,59,1.19 [0.72-1.97],0.4879741051541901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,22695,72,0.76 [0.46-1.27],0.2956684914085057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C5,Complement C5,19729,64,0.64 [0.24-1.68],0.3623368755815866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19252,62,1.78 [0.81-3.93],0.1535636427714519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,19658,61,1.06 [0.40-2.84],0.9037764917247276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,19729,64,0.63 [0.30-1.35],0.2367683456439903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,19703,63,0.57 [0.37-0.88],0.0106800871563225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,19597,60,1.02 [0.76-1.36],0.8918505492294705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,22090,68,1.04 [0.75-1.46],0.7980824839695527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,22112,69,1.61 [1.11-2.34],0.0129477392487991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,22521,70,1.91 [1.09-3.34],0.0232346886865202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,22387,71,1.08 [0.88-1.33],0.4713593433426073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,22825,71,1.36 [0.74-2.50],0.3161754279663492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,22554,68,1.07 [0.80-1.43],0.6639095192515072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,22858,73,1.07 [0.77-1.49],0.6833449480512421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,22897,73,0.68 [0.28-1.63],0.3838509738460193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",22222,70,1.31 [1.06-1.60],0.0103415406345247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,22558,68,0.96 [0.68-1.35],0.8083376162881563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,19320,61,0.88 [0.43-1.82],0.7281000893262828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,19152,63,0.77 [0.27-2.20],0.6221658798286405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,22825,71,1.71 [1.15-2.55],0.0086507913377788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,19152,61,1.02 [0.70-1.48],0.9071402797830724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19090,59,1.16 [0.58-2.32],0.6844995265067828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19099,60,0.99 [0.66-1.50],0.969452629430462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19090,59,1.11 [0.76-1.64],0.5843116681596932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19667,61,1.08 [0.81-1.44],0.5973581415311474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,19245,62,1.12 [0.88-1.43],0.3450532775404324
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,19152,61,0.69 [0.35-1.38],0.296206632503656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,22521,70,0.89 [0.55-1.43],0.6200718471651829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,22060,66,0.86 [0.42-1.77],0.6757639967993272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,22421,64,1.13 [0.78-1.66],0.5182698046502829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,19658,61,1.63 [1.15-2.32],0.0061239263040574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22752,71,1.11 [0.90-1.36],0.3266595565199568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19200,61,1.12 [0.82-1.53],0.4855537475674707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,19099,60,0.70 [0.32-1.52],0.3719920874732577
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22112,69,1.07 [0.66-1.75],0.7809561404526705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19152,61,0.77 [0.47-1.28],0.3151767176871379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19667,61,1.17 [0.93-1.46],0.1790111130534506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,22560,72,1.44 [0.51-4.03],0.489538350849597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,22472,71,0.90 [0.62-1.30],0.5672958854950367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,19591,60,0.58 [0.26-1.32],0.1934661983407667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,19658,61,1.19 [0.99-1.42],0.0608642601850836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,22060,66,1.21 [0.82-1.78],0.3483714497088566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,19152,61,1.07 [0.60-1.93],0.8143332540396977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,22060,66,1.10 [0.81-1.48],0.5488072967076298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,22060,66,1.01 [0.74-1.38],0.9291506515874683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,22585,70,1.07 [0.79-1.45],0.6656946305724808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,22897,73,1.13 [0.89-1.43],0.3088789765414744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,19320,61,1.04 [0.91-1.19],0.5264238142610594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,19658,61,0.95 [0.71-1.28],0.7579774280287002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,22753,71,1.20 [0.88-1.65],0.2543756158845922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,19152,63,1.07 [0.73-1.56],0.7416211888261727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,19099,60,0.89 [0.51-1.55],0.67696637157312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CAT,Catalase,19400,62,1.08 [0.71-1.67],0.7141363876617148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,22591,71,1.23 [0.93-1.62],0.1402351365301457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,19090,59,1.09 [0.88-1.36],0.437003313375791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,22825,71,1.20 [0.63-2.28],0.5856710089739465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,19200,61,1.75 [1.25-2.46],0.0012162318254094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,19099,60,0.63 [0.28-1.40],0.2568133804070228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22470,65,1.13 [0.85-1.51],0.4036110816979154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,19658,61,0.87 [0.52-1.44],0.5866216123147114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,19591,60,1.11 [0.69-1.80],0.666752845518277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,19152,61,0.63 [0.27-1.46],0.2804919153629416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,19667,61,1.02 [0.75-1.38],0.9192954675378104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,22626,72,1.24 [0.70-2.21],0.4638240417216939
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19200,61,0.94 [0.63-1.41],0.7689690175339571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,22873,71,1.26 [0.72-2.22],0.4178199542595548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,22833,71,1.12 [0.83-1.50],0.4713071939278936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,22540,69,1.07 [0.62-1.83],0.8184790479574884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,22897,73,1.93 [1.28-2.90],0.0016216016652095
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,22897,73,1.55 [1.02-2.37],0.0418733051351064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,22593,71,0.95 [0.75-1.20],0.6504308637820839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,22276,69,1.17 [0.89-1.53],0.2700107612173599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,22821,68,1.00 [0.86-1.18],0.9522817534260926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,22435,65,1.22 [0.82-1.82],0.3185653554601187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,22873,71,1.13 [0.92-1.39],0.2307323011655759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,22729,72,1.20 [0.79-1.83],0.388260429629128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,22402,71,1.29 [0.88-1.90],0.1962998197084221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,22729,72,1.19 [0.72-1.97],0.4910182825162643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,22690,72,1.12 [0.88-1.43],0.3599341045203778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,22873,71,1.38 [0.90-2.13],0.1431895639360692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,22585,70,0.86 [0.66-1.11],0.2373299503648367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,22626,72,0.94 [0.66-1.34],0.730910238857629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,22510,70,0.93 [0.64-1.35],0.6971620844915762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,22585,70,1.34 [1.07-1.68],0.0103487165116403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,22660,71,1.27 [1.02-1.57],0.0327423722892232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,22687,71,1.00 [0.81-1.23],0.9921256179469602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,22585,70,0.99 [0.69-1.42],0.9580688116599694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,22792,71,0.85 [0.61-1.19],0.3495654172894867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,22481,70,1.18 [0.89-1.56],0.259636825246595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,22617,72,1.03 [0.71-1.48],0.8897187658116533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,22863,72,2.21 [1.32-3.71],0.002537078893124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,22825,71,1.25 [0.77-2.03],0.3750526968269615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,22630,68,0.87 [0.50-1.51],0.6128998480499264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,19320,61,1.07 [0.55-2.08],0.8455877179157958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,19152,63,0.77 [0.51-1.15],0.1994961251711999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,22470,65,1.20 [0.77-1.88],0.4135306321597333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,22112,69,1.13 [0.71-1.78],0.6150386593413109
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,19597,60,0.74 [0.43-1.29],0.2928492581534883
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,22630,68,2.01 [1.05-3.84],0.0342740268044171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,22123,69,1.67 [1.06-2.62],0.0278558414068741
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,22873,71,0.96 [0.61-1.52],0.8668609094097514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,22687,71,2.31 [1.51-3.55],0.0001252673164866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,22630,68,0.98 [0.42-2.28],0.9590060747668904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,19152,61,1.11 [0.58-2.11],0.7530134494613833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,22601,68,1.14 [0.95-1.37],0.1496430773759136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,22695,72,1.16 [0.48-2.80],0.7478092678949484
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,19099,60,1.27 [0.77-2.09],0.3523508420627179
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,22585,70,1.84 [0.81-4.15],0.144445011665514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,22517,70,1.33 [0.72-2.43],0.3622242690980605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,22129,70,2.85 [1.81-4.50],6.514057412911859e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,22672,71,0.86 [0.50-1.49],0.5954418521022995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,22873,71,1.27 [0.76-2.13],0.3552553725320427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,19152,63,0.71 [0.39-1.29],0.2605839188258067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,22873,71,1.38 [0.63-3.00],0.417713427411331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,19695,63,1.05 [0.57-1.91],0.8792883342293193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,22695,72,1.16 [0.69-1.94],0.5813610631927675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,22470,65,1.61 [0.91-2.85],0.103715786095346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,22620,72,1.52 [0.84-2.75],0.1624914417244408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,22112,69,1.62 [1.00-2.63],0.0519444093129691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,22626,72,1.19 [0.86-1.63],0.2896703698004785
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,19288,62,1.76 [0.79-3.91],0.1674936196877132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,22821,68,1.55 [0.85-2.83],0.1555646829476312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,22746,71,1.05 [0.62-1.78],0.8575435772067797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,22825,71,1.45 [0.98-2.14],0.0649139985971844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,22630,68,1.32 [0.75-2.33],0.3341316853144559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,22521,70,1.88 [0.97-3.62],0.0598403312307972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,22695,72,1.18 [0.90-1.55],0.2307497386614579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,22738,67,0.79 [0.32-1.95],0.6136638501120357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,19152,63,0.77 [0.43-1.36],0.3638024387097416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22521,70,1.90 [0.99-3.67],0.0551721004627697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,19090,59,0.78 [0.33-1.80],0.554936485592189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,19320,61,0.48 [0.20-1.18],0.1092797355217479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,19152,63,0.91 [0.68-1.23],0.5540035701054415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,22543,70,1.60 [1.00-2.58],0.0513126827087052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,22621,71,1.47 [1.00-2.18],0.0525502843761359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,22873,71,1.03 [0.78-1.35],0.8370615392586194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,22459,69,2.10 [1.15-3.82],0.0154218734182371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,22690,72,1.72 [0.86-3.48],0.1278025590980118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,22792,71,1.64 [0.88-3.06],0.1186331942743004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,21813,68,1.92 [1.03-3.60],0.0410068281307985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,22586,72,3.07 [0.92-10.18],0.0671935142232066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,21788,69,1.54 [0.63-3.76],0.3462362914609567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,19611,63,1.02 [0.61-1.71],0.9444004216866504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,22833,71,1.24 [0.84-1.83],0.2824668960854597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,22435,65,0.85 [0.56-1.30],0.4505883926261699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,22528,71,1.01 [0.79-1.28],0.9402433998448232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,19111,61,0.64 [0.35-1.17],0.1479588310707903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,22585,70,0.78 [0.47-1.30],0.3413445513579873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19288,62,1.10 [0.61-1.97],0.7575334805842842
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,22821,68,1.54 [0.85-2.80],0.1540038202333716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,22873,71,1.51 [0.95-2.40],0.0819916475264331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,19699,63,2.51 [1.34-4.67],0.0038276659409125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,19320,61,1.22 [0.74-2.00],0.4354442922937401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,22585,70,1.81 [0.99-3.30],0.0538384771689167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,22585,70,1.17 [0.59-2.33],0.6484966862392606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,19597,60,1.74 [0.75-4.05],0.1994858205919614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,22821,68,1.44 [0.95-2.18],0.085342129051572
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,21736,66,2.12 [1.13-3.98],0.0189437288861618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,22630,68,1.29 [0.43-3.88],0.6498818818386655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,22630,68,1.82 [0.74-4.46],0.1892588169342558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,19658,63,0.63 [0.37-1.09],0.0989697700776964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,19658,61,0.75 [0.24-2.32],0.6174815612934181
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,19005,60,1.24 [0.91-1.69],0.1644493022644448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,19005,60,0.50 [0.24-1.03],0.0616173143289682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,19569,60,1.27 [0.90-1.79],0.1707368186362243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,22112,69,0.99 [0.69-1.41],0.9533417202853384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,22695,72,1.10 [0.86-1.41],0.4327145142629888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,19597,60,1.10 [0.87-1.39],0.4321030679524169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,22470,65,1.50 [1.00-2.25],0.050465710386434
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,21836,66,1.43 [0.91-2.25],0.1206423421620748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,22772,67,1.81 [1.32-2.49],0.0002494051226777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,22626,72,1.52 [1.16-2.00],0.0027743844000486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,22626,72,2.15 [1.20-3.85],0.0102006507232048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,19320,61,1.91 [1.09-3.34],0.0237671245642784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,19658,61,0.71 [0.27-1.87],0.4930928319086918
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,22821,68,1.13 [0.62-2.06],0.7001004659999049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,19090,59,1.10 [0.68-1.79],0.6883744478745557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,22897,73,1.53 [0.79-2.94],0.2036210744395861
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,22626,72,3.13 [1.90-5.14],6.737132257560658e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,22060,66,1.13 [0.69-1.84],0.6255686211883251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,22521,70,1.51 [1.14-1.98],0.0034420140957294
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,22626,72,0.84 [0.50-1.43],0.5292569932416169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,19005,60,0.98 [0.50-1.92],0.9484939673271848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19667,61,1.08 [0.72-1.62],0.7141103151936592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,19090,59,1.06 [0.69-1.64],0.7877544954649509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,22521,70,1.17 [0.96-1.43],0.1197212169161913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22521,70,1.11 [0.88-1.41],0.3597036803817522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,22521,70,1.14 [0.60-2.18],0.682301633597155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22662,72,2.16 [0.96-4.84],0.0615937980222071
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,22793,71,1.02 [0.63-1.65],0.9383680285459506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22657,72,4.26 [1.68-10.80],0.0022476796279079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19597,60,1.11 [0.81-1.53],0.5207488510729148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19320,61,0.94 [0.65-1.37],0.7535086217493969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19597,60,0.57 [0.31-1.06],0.0751646843444933
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19320,61,1.06 [0.63-1.79],0.8232811600200941
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22585,70,0.98 [0.77-1.26],0.8986460565854473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22112,69,0.90 [0.57-1.43],0.6649749810980868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21810,69,1.41 [1.04-1.89],0.0248435772791043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19695,63,0.92 [0.48-1.76],0.8061015919563077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22222,70,1.03 [0.67-1.59],0.8925989918081433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,19152,63,0.94 [0.48-1.85],0.8646738144185497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,22222,70,0.96 [0.55-1.69],0.8893456025529507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,19695,63,0.74 [0.50-1.10],0.1353030729174562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,22859,73,1.34 [0.94-1.92],0.1093997702403974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19288,62,1.47 [0.63-3.42],0.3720096616410394
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,19152,63,1.50 [0.99-2.28],0.0564548852947824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,19090,59,0.91 [0.58-1.45],0.7034696554515496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,19320,61,1.12 [0.73-1.71],0.614764662960099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,19320,61,1.07 [0.77-1.48],0.684588436634429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,19099,60,1.70 [1.25-2.30],0.0006653402932074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,19005,60,1.26 [0.76-2.07],0.3691741894374839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,22198,70,0.92 [0.64-1.33],0.6617555456245908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,19200,61,1.14 [0.84-1.56],0.4033297345063446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,22112,69,1.17 [0.89-1.55],0.2637739811259764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,19320,61,0.92 [0.56-1.49],0.7281761497596311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,19005,60,1.28 [0.73-2.26],0.3865927478515295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,22046,70,1.14 [0.84-1.54],0.4067872087579827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,22112,69,1.28 [0.93-1.75],0.1323831759772483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,22060,66,1.06 [0.74-1.52],0.7540945102361701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,22670,71,1.29 [1.02-1.64],0.0341646527121856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,22521,70,1.58 [1.12-2.22],0.0087161645527832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,22521,70,1.14 [0.86-1.51],0.3553883120580335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,22060,66,1.00 [0.72-1.38],0.9805924036986028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,19597,60,1.05 [0.76-1.45],0.7619542904646142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,19352,62,1.15 [0.54-2.47],0.7136485571994511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,22112,69,1.37 [0.91-2.05],0.1290297029412007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,19729,64,0.36 [0.11-1.24],0.1056214757883522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,18562,60,1.29 [0.43-3.81],0.6491740288474437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,19584,61,0.65 [0.46-0.92],0.0155459915020102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,19698,64,0.84 [0.62-1.15],0.2835717577434362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,19437,63,0.62 [0.40-0.96],0.0314645056405726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,19729,64,0.53 [0.16-1.72],0.29174757740473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CFP,Properdin,19729,64,0.56 [0.17-1.78],0.323253850991867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,22630,68,1.35 [0.99-1.82],0.0544125663053619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19703,63,1.25 [0.82-1.92],0.2978712491161075
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,19152,61,1.43 [0.95-2.17],0.0902506977731683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,22626,72,1.25 [0.77-2.05],0.3674725183561379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22112,69,1.23 [0.90-1.69],0.199315853773511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,19288,62,1.21 [0.76-1.93],0.4225167080928966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19658,61,2.23 [1.41-3.52],0.0005974212262753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,19591,60,1.39 [0.68-2.82],0.3621648155671754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,22222,70,0.67 [0.35-1.29],0.2319220867146353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,19695,63,1.14 [0.91-1.43],0.2557252764486716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,22727,65,1.15 [0.67-1.98],0.6211033416100344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,22097,69,1.44 [1.13-1.83],0.0029697565291804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,22717,72,0.93 [0.83-1.04],0.2175788466420462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,22650,71,0.96 [0.49-1.88],0.905434909026544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,19152,61,1.27 [0.88-1.84],0.2043270311929001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,22470,65,1.02 [0.77-1.35],0.8836985815141957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,19699,63,1.13 [0.73-1.75],0.5758587059857064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,19090,59,0.83 [0.56-1.21],0.3313147907107368
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,22690,72,2.80 [1.45-5.39],0.0020651298779234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,22626,72,1.14 [0.78-1.68],0.495772419034743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,19152,61,1.55 [0.97-2.48],0.0660979896235175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,22695,72,1.25 [0.90-1.73],0.1812980703063756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,19695,63,1.03 [0.66-1.61],0.9059218096518245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,19320,61,1.00 [0.57-1.73],0.9936337590615478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,19597,60,1.08 [0.83-1.40],0.581165923626227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,19152,61,1.32 [0.82-2.12],0.2450760954028356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,22764,70,1.95 [0.96-3.94],0.0634663339829566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,19695,63,1.31 [0.89-1.94],0.1757647273829961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22545,71,1.21 [0.88-1.68],0.2350402846830697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,19005,60,0.94 [0.66-1.35],0.7508846188450651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,22591,72,1.26 [0.94-1.68],0.1193670547289632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,22470,65,0.95 [0.51-1.77],0.8769240301022816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,22581,67,1.40 [0.89-2.18],0.1447059050816236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,19152,63,0.49 [0.15-1.65],0.2507711116727034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,22630,68,1.59 [0.82-3.05],0.1674657218909954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,22222,70,1.45 [0.77-2.72],0.2535325187846083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,22821,68,0.92 [0.74-1.15],0.474004603375285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,19152,61,0.80 [0.45-1.42],0.4429989672541298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,19254,62,0.62 [0.19-2.01],0.4207475326323558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,22585,70,0.83 [0.45-1.53],0.546808034262804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,22585,70,1.33 [0.85-2.07],0.2125382833809645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,22585,70,1.43 [1.03-2.00],0.0347568181964184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,22585,70,0.82 [0.43-1.56],0.5433925106372193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,19656,63,1.05 [0.64-1.73],0.8385276156369287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,22558,71,1.07 [0.52-2.23],0.8482525992858647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,22112,69,1.39 [0.90-2.15],0.1321969787408203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,22873,71,1.34 [0.86-2.07],0.1919303138140233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,19152,61,1.67 [1.07-2.61],0.0245190708859748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,19152,61,1.26 [0.65-2.45],0.499251350738029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,19005,60,1.29 [0.87-1.90],0.209514586247945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,22585,70,1.01 [0.83-1.22],0.9383846608106672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,22825,71,1.72 [0.61-4.86],0.303363450748118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,19152,61,1.12 [0.54-2.30],0.7606506173485046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22421,64,1.03 [0.82-1.30],0.7781940046482038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,22595,68,1.22 [0.89-1.66],0.2154626499132927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,22011,65,0.86 [0.42-1.77],0.6847262321743877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,22060,66,0.70 [0.43-1.12],0.1347923395478612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,22873,71,1.83 [1.19-2.82],0.0056826289505676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,19658,61,1.68 [0.82-3.43],0.1555812187270028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,22222,70,0.97 [0.61-1.52],0.8784469960117361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,19729,64,0.81 [0.32-2.10],0.6700831265265602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,22595,72,1.48 [0.95-2.30],0.0839933341136337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,19699,63,1.07 [0.83-1.40],0.5934355021125416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,19591,60,1.16 [0.86-1.56],0.3251689244431947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,22687,71,0.78 [0.51-1.21],0.2735265633494314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,19090,59,1.11 [0.75-1.67],0.5986805787768203
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19163,61,1.13 [0.83-1.53],0.4444114487140196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,22222,70,0.78 [0.51-1.20],0.25957377936267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,22521,70,1.15 [0.86-1.52],0.3427589904402953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNST,Consortin,22626,72,1.01 [0.83-1.23],0.8974175546337796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,19090,59,0.77 [0.37-1.61],0.4877103596610457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,22897,73,2.34 [1.10-4.94],0.0264974151870012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,22825,71,1.55 [0.99-2.42],0.0560213386008422
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,22630,68,1.40 [0.74-2.62],0.2995470922985206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,22630,68,1.12 [0.46-2.72],0.8043097972992765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,22672,67,1.05 [0.58-1.87],0.8816938756862058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,22585,70,2.00 [1.25-3.23],0.0041926516657242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,19152,61,0.86 [0.64-1.15],0.3047943546065997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,19699,63,1.17 [0.71-1.94],0.5341724558591983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,19695,63,1.29 [0.52-3.17],0.5833859339015723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,22719,71,2.43 [1.00-5.92],0.0510318752895319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,22897,73,2.61 [1.20-5.66],0.015418429460697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,19597,60,1.81 [1.12-2.94],0.0161552827395834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,19152,61,1.14 [0.82-1.57],0.4328648923329788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,19200,61,1.02 [0.76-1.38],0.8866154150025239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,19695,63,1.32 [0.47-3.70],0.5973799508127877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,22626,72,1.74 [1.06-2.85],0.0283613358970426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,19289,61,0.96 [0.61-1.51],0.8497272420945634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19288,62,2.65 [1.70-4.12],1.6804039300143384e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,22897,73,2.29 [1.36-3.87],0.0018515699755985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,22585,70,1.16 [0.77-1.74],0.4852713761369929
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,19320,61,0.91 [0.52-1.59],0.7463220662053643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,22620,72,1.77 [0.80-3.93],0.1570547746418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,19200,61,1.17 [0.79-1.74],0.4223418671649409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,19591,60,0.74 [0.37-1.47],0.3910379223935712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,22358,69,1.44 [0.76-2.73],0.2621025084584022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,21987,70,1.06 [0.82-1.36],0.6713596482412006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',19099,60,1.42 [0.85-2.37],0.1841853970757241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,22060,66,1.12 [0.73-1.71],0.6065054151250248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19200,61,2.18 [1.60-2.96],6.580731792108856e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,22137,67,1.14 [0.92-1.43],0.2328945555977466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,19090,59,1.29 [0.72-2.33],0.3953839868677462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22521,70,1.18 [0.88-1.57],0.2608844053942846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,19699,63,1.01 [0.48-2.13],0.9688221965840096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,22897,73,1.12 [0.79-1.59],0.5209856686478367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,22734,67,1.20 [0.87-1.66],0.2625249684499429
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,18897,61,1.61 [0.90-2.88],0.10672483649615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,22897,73,1.19 [0.84-1.69],0.3342148031833845
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,19685,64,0.48 [0.17-1.40],0.1797147455589601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,22663,71,0.73 [0.45-1.19],0.2041001818017265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,19005,60,1.32 [0.68-2.56],0.413712864236922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,22710,64,1.65 [0.89-3.04],0.1114966066028558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19152,63,0.98 [0.41-2.32],0.9622843414313198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,22821,68,0.98 [0.71-1.35],0.9130388525427428
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,19653,63,1.84 [0.91-3.73],0.0912070224433346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,19099,60,1.25 [0.72-2.16],0.4220601118640704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,22797,71,2.46 [1.43-4.25],0.0011715506647698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,22695,72,0.90 [0.67-1.22],0.5032545684014589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,19699,63,1.73 [0.86-3.49],0.1267557342477024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,19621,62,2.92 [1.54-5.53],0.0010179175756493
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,22687,71,1.78 [1.15-2.76],0.0103015061497724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22112,69,1.00 [0.78-1.28],0.993536917442095
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,22421,64,1.02 [0.76-1.37],0.8829833689511538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,19005,60,0.93 [0.59-1.47],0.7556084368101691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,19005,60,0.47 [0.17-1.31],0.1471590823000633
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22327,71,1.75 [1.02-2.99],0.0414112007440825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19288,62,1.57 [0.83-2.97],0.1638786356921992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,22690,72,1.22 [0.82-1.80],0.3214011340925033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,22071,69,1.03 [0.80-1.32],0.8372368789624968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,22620,72,1.56 [0.73-3.30],0.2479318411576158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,22222,70,0.84 [0.57-1.22],0.3586147148404028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,22729,72,4.60 [1.88-11.27],0.000836663151261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,22470,65,1.41 [0.84-2.37],0.1980638794536494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,22825,71,1.03 [0.74-1.45],0.8415674436507601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,19523,63,0.51 [0.22-1.20],0.1235745531593004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,22656,72,1.11 [0.91-1.36],0.2860169684744409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,22729,72,1.20 [0.52-2.77],0.6614812564360628
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,21984,71,1.20 [0.88-1.63],0.2509631512633831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,22897,73,0.68 [0.35-1.34],0.2641149211328895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,22470,65,1.63 [1.06-2.50],0.0256200263084486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,19152,61,1.11 [0.70-1.77],0.6492919596798347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,22222,70,0.81 [0.62-1.05],0.1118691729247955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,19699,63,1.15 [0.79-1.67],0.4564191108402274
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,19658,61,1.03 [0.75-1.42],0.8494596895519942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,19658,61,1.20 [0.93-1.54],0.1684935460153289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,19090,59,0.98 [0.70-1.37],0.917587944212386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,19200,61,1.11 [0.85-1.46],0.4288895130865611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,19099,60,1.13 [0.94-1.35],0.1908050093619831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,22729,72,1.89 [0.91-3.93],0.0887401861654376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,19703,63,2.21 [1.29-3.76],0.003618574215305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19099,60,1.58 [0.87-2.87],0.1312674845042145
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22470,65,1.43 [1.07-1.92],0.0169491842154438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,19152,63,0.86 [0.50-1.50],0.6021338934978285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22198,70,0.83 [0.53-1.30],0.4073384320747825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,19152,63,1.19 [0.56-2.55],0.6554697755490148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,19703,63,1.14 [0.56-2.31],0.7200107453190601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,19152,63,1.01 [0.69-1.47],0.9754253197717476
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,19667,61,1.21 [0.71-2.06],0.4910285568243387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,19695,63,1.54 [0.74-3.20],0.249824210125386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,19090,59,1.10 [0.69-1.74],0.6953710469937848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,19099,60,0.97 [0.74-1.27],0.8180801441355925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,17091,54,1.11 [0.86-1.44],0.4113027104813872
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,22654,71,1.66 [0.81-3.40],0.1687697729101108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,22239,65,1.52 [1.04-2.23],0.0301691849535122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,22049,69,1.24 [0.79-1.95],0.3396230937224286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,22660,71,0.89 [0.69-1.14],0.3607558053258414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,22312,70,1.22 [0.74-2.01],0.4441167787013671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,19277,61,0.96 [0.59-1.58],0.8800388657539718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,19408,62,1.11 [0.44-2.80],0.8212613467719253
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,22222,70,1.13 [0.89-1.44],0.3249530160130311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,19695,63,1.95 [0.91-4.17],0.0845764103215946
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,19695,63,0.84 [0.37-1.92],0.6761606884543968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,19090,59,0.99 [0.50-1.96],0.9849758347627424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,22630,68,1.14 [0.77-1.69],0.5077725069570693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,22629,72,1.43 [1.04-1.97],0.0280891263267287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,19658,61,0.81 [0.57-1.17],0.2653546253072853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,22643,71,1.51 [1.05-2.17],0.0276348907000816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,22585,72,1.75 [1.12-2.72],0.0133735903715967
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,21098,64,1.49 [0.94-2.36],0.089569635593064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,19288,62,1.14 [0.71-1.82],0.5964046334743381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,22695,72,1.66 [1.00-2.77],0.0508025254144089
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,22160,70,1.03 [0.77-1.38],0.8569151208805307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,22626,72,2.79 [1.25-6.22],0.0119164923505464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,22873,71,1.75 [0.91-3.37],0.0962500384464841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,17759,49,1.34 [0.43-4.17],0.6161501316319442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,22766,71,0.83 [0.50-1.38],0.469320716499532
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,22608,71,2.16 [1.14-4.11],0.0184820792209151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,19152,61,0.98 [0.49-1.95],0.9435461649307968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,19478,59,0.91 [0.59-1.41],0.6750055809780534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,22470,65,1.25 [0.67-2.36],0.4822325706877659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,22585,70,1.97 [1.46-2.66],8.741616848085421e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,22585,71,1.05 [0.85-1.29],0.6433123524256734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,22729,72,1.07 [0.79-1.44],0.6534160730687559
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,22821,68,1.14 [0.90-1.46],0.2714982190268101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,22198,70,1.31 [0.79-2.16],0.2965315522920504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,22821,68,1.09 [0.80-1.49],0.576970487153815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,22198,70,0.99 [0.70-1.41],0.9616792880422224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,22858,73,1.04 [0.43-2.50],0.9305530108589776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,22873,71,1.23 [0.75-2.01],0.4095728651814615
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,22621,71,1.07 [0.86-1.35],0.529638380052698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,22553,72,1.02 [0.85-1.22],0.8089707682525459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,22873,71,1.20 [0.93-1.56],0.168176860778641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,22450,71,1.32 [1.05-1.67],0.018307190694702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,22729,72,0.88 [0.63-1.23],0.4650026318364272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,19005,60,1.08 [0.80-1.46],0.6099897609871858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,19354,59,1.11 [0.72-1.71],0.6401312801224288
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19099,60,0.93 [0.69-1.27],0.6670619934974759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,19005,60,0.95 [0.67-1.35],0.7602374835359884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,19695,63,1.22 [0.44-3.43],0.6995400464639755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,19288,62,1.18 [0.88-1.58],0.259496334244668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,22825,71,1.11 [0.92-1.35],0.2764298915140502
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,22729,72,1.46 [0.94-2.26],0.089629625110042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,19152,63,1.39 [1.04-1.86],0.0267979592758884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,19152,63,1.34 [0.95-1.89],0.092352581385472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22585,70,1.06 [0.89-1.28],0.5086817267655059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",22421,64,0.98 [0.72-1.32],0.8841778745493056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,19662,63,0.91 [0.74-1.12],0.390210568394589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,22531,68,1.09 [0.83-1.44],0.5439973309970829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,19152,63,1.15 [0.73-1.83],0.5477018625601076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,22729,72,1.12 [0.89-1.40],0.341751084447634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22695,72,1.73 [0.96-3.12],0.0684008521373447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,19152,61,0.96 [0.33-2.78],0.937100278443522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,19005,60,1.17 [0.84-1.63],0.3520679119235206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,19005,60,0.63 [0.27-1.46],0.2781157014621485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCN,Decorin,22222,70,1.03 [0.41-2.60],0.9527507791095472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,19288,62,1.14 [0.87-1.48],0.3425222071157204
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,22825,71,1.19 [0.87-1.63],0.2838385706000819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,22521,70,1.03 [0.82-1.29],0.8009130895908441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,22060,66,1.07 [0.80-1.43],0.6501056863523904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,22626,72,1.76 [0.90-3.42],0.098308515843138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,19090,59,0.89 [0.62-1.28],0.5375857234259479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,19005,60,1.10 [0.84-1.44],0.4910343398141761
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,22695,72,1.25 [0.86-1.82],0.2410622911201972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,19099,60,0.97 [0.52-1.79],0.9143709441433456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22521,70,1.48 [0.96-2.28],0.072240736400801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,22591,71,1.21 [0.79-1.85],0.3884258171629245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,19667,61,1.15 [0.80-1.67],0.4490152223499166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,19288,62,1.11 [0.82-1.49],0.496977644741238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,22821,68,2.93 [1.29-6.67],0.0104283076217133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,19695,63,1.67 [1.05-2.67],0.0307185704750712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,19597,60,1.04 [0.65-1.67],0.8548920676377232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,19152,61,1.01 [0.54-1.89],0.9635919772438036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,19152,63,2.20 [1.07-4.54],0.0328085418370695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,19152,63,1.19 [0.82-1.74],0.3634097939071118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,19152,61,1.43 [0.75-2.72],0.2829231224868557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,22112,69,1.23 [0.89-1.68],0.2052656667219606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22585,70,1.01 [0.81-1.26],0.9032643849757812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,22145,70,1.03 [0.69-1.54],0.8713716387051151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,18999,62,0.76 [0.38-1.53],0.4429177560257847
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,19090,59,0.80 [0.48-1.35],0.4047190288282275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,19090,59,0.45 [0.26-0.78],0.0043720937249483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,19090,59,1.12 [0.77-1.61],0.5591088332647852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,22315,69,1.07 [0.93-1.23],0.3565411807102374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,19099,60,0.65 [0.34-1.25],0.1967143409953125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,19152,63,1.17 [0.80-1.73],0.4144320341868538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,22873,71,1.16 [0.86-1.57],0.3301397961614731
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,19090,59,1.28 [0.85-1.95],0.2410668811805478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,19152,63,1.33 [0.88-2.03],0.1798859118712914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,22198,70,0.86 [0.47-1.59],0.6322833246601569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,19099,60,0.99 [0.60-1.65],0.9727858419374432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,19591,60,1.20 [0.72-1.99],0.4795737292488754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19658,61,1.29 [0.81-2.04],0.2855660054460843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",22558,71,1.08 [0.89-1.30],0.4577104349070473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,19152,61,0.73 [0.38-1.40],0.3370424082548811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19288,62,2.50 [1.17-5.35],0.0178487763571007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,22821,68,0.90 [0.63-1.29],0.5671778325631756
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,22897,73,3.17 [1.65-6.11],0.0005680163295997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,22439,65,1.63 [1.07-2.49],0.0234556697364338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,22521,70,1.18 [0.90-1.53],0.22625520664545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,19658,61,1.17 [0.84-1.62],0.3542165803569418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,19667,61,1.01 [0.65-1.58],0.9653576573837126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,22897,73,1.21 [0.83-1.78],0.3259328174279755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,22695,72,2.48 [1.29-4.76],0.0063649317811553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,19200,61,1.08 [0.86-1.36],0.5176270053147873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,19200,61,1.07 [0.67-1.70],0.7773743918862824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19200,61,1.62 [1.04-2.52],0.0332889430385102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,19005,60,0.78 [0.42-1.43],0.4178123365389037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,22804,70,1.06 [0.82-1.37],0.6355726490418405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,19658,61,0.98 [0.70-1.37],0.902864051385051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,22521,70,1.05 [0.83-1.33],0.6944436199357568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,19597,60,0.93 [0.63-1.37],0.7260358707514338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,19288,62,1.23 [0.80-1.89],0.3439140280296419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,19096,61,1.26 [0.94-1.68],0.1185567143930582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,22222,70,0.97 [0.67-1.40],0.8633800106580096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,19658,61,1.55 [0.89-2.69],0.1219766182487111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,19200,61,1.06 [0.79-1.42],0.6888264989111403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,19597,60,1.25 [0.92-1.71],0.1590338169433701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,22588,72,1.54 [0.66-3.59],0.317235172218432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,19090,59,0.86 [0.63-1.18],0.3469778311687654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,19597,60,1.06 [0.85-1.32],0.6288886421032975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,19667,61,1.19 [0.78-1.82],0.4181236670479098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,22470,65,1.06 [0.75-1.51],0.7340087843566017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,19658,61,1.31 [0.86-1.99],0.2165598647282072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22695,72,1.26 [0.86-1.85],0.2391769919449812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,19152,61,1.10 [0.58-2.08],0.7781474190684977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,19090,59,1.05 [0.87-1.28],0.600193202249006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,19658,61,1.09 [0.90-1.31],0.386462905888451
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,22626,72,1.08 [0.91-1.29],0.3580253439526001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,22421,64,0.97 [0.63-1.49],0.8757386784845679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,22521,70,0.74 [0.35-1.57],0.4331340734409937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,22585,70,2.24 [1.38-3.61],0.0010182964198295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22176,68,2.69 [1.40-5.16],0.0029833607494043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,22521,70,1.48 [0.79-2.80],0.2220272175299554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,22437,71,1.37 [0.96-1.96],0.0826496553041778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,22897,73,2.70 [1.13-6.44],0.0248554346385928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,22752,71,1.37 [1.01-1.84],0.0421431653461122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,22470,65,1.44 [0.88-2.37],0.1474524982679194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,22521,70,1.20 [0.83-1.73],0.3390710195186033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,22385,68,2.21 [1.31-3.72],0.0029551895860653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,19667,61,0.95 [0.47-1.91],0.8839985220297161
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,22630,68,1.28 [0.59-2.80],0.5340466371238506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,22757,71,0.72 [0.38-1.35],0.3051722001747987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,22441,70,1.26 [0.83-1.91],0.278172353566248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,19288,62,1.13 [0.86-1.50],0.3804250406810658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,19563,60,1.70 [1.02-2.84],0.0430972468134922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,19152,61,0.70 [0.44-1.11],0.1309659367118983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,22521,70,1.89 [0.83-4.30],0.1264561369103174
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,19699,63,1.06 [0.75-1.50],0.7253515400239655
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,22222,70,0.69 [0.47-1.01],0.0581198041045925
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,19591,60,0.87 [0.47-1.63],0.6702851691187064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,19152,61,1.13 [0.82-1.57],0.4528014394568747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,22060,66,1.04 [0.82-1.32],0.7298017534708158
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19597,60,0.98 [0.77-1.25],0.8730150965971797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,19658,61,1.46 [0.88-2.44],0.1464597722863888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19591,60,1.23 [0.81-1.87],0.3393970724465242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,19152,61,1.03 [0.77-1.38],0.8348291353410698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,19591,60,1.28 [0.75-2.18],0.3732904621721101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22470,65,1.07 [0.85-1.35],0.5666410206008917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,22786,71,2.15 [1.16-3.98],0.0147182314992192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,22060,66,1.60 [0.90-2.83],0.1102810646648613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19699,63,1.38 [1.05-1.82],0.0194778027290625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",19200,61,1.26 [0.99-1.61],0.0643729864745591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,19099,60,1.33 [0.95-1.87],0.0999865138244839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,19164,62,1.07 [0.55-2.09],0.8432074698283112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,19090,59,0.68 [0.36-1.28],0.2288154024306337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,22825,71,2.24 [1.34-3.77],0.0022148020643265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,22585,70,0.88 [0.69-1.11],0.2648890211089234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,19591,60,1.57 [1.02-2.42],0.0419441415783994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19099,60,0.89 [0.43-1.82],0.7398982761740105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,19667,61,1.18 [0.87-1.59],0.2896247873465791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22222,70,0.93 [0.50-1.75],0.8272961074871541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,19200,61,1.58 [0.68-3.66],0.2871870763997576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,19152,63,1.02 [0.59-1.74],0.9556633059899128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,19699,63,1.10 [0.85-1.42],0.4498076639522103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,19597,60,1.52 [0.70-3.29],0.2905889164202303
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,19320,61,1.62 [0.92-2.88],0.097111487084498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22648,71,1.81 [0.93-3.51],0.0812503303211093
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,19667,61,1.46 [0.79-2.67],0.2263206054937328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,22596,68,1.56 [0.73-3.36],0.2531532480404892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,22435,65,1.69 [0.83-3.44],0.1511461806169001
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,19152,61,1.12 [0.76-1.64],0.5734668622774107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,22590,72,0.97 [0.80-1.19],0.802129347310022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,22112,69,1.33 [0.83-2.12],0.2383943476874536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,19597,60,0.92 [0.40-2.08],0.8319986791241482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,22897,73,0.47 [0.21-1.03],0.0596520155412772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,22585,70,1.19 [0.87-1.62],0.2744741176583478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,19699,63,1.23 [0.90-1.68],0.2045609728299866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,19200,61,1.04 [0.84-1.29],0.719083426322312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19658,61,1.22 [0.83-1.79],0.3071763538868453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19528,59,1.02 [0.81-1.29],0.8442008410259881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19099,60,1.06 [0.73-1.52],0.7733178744358418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19200,61,1.52 [0.93-2.48],0.0987051323469519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,22470,65,1.07 [0.73-1.56],0.7326964281188839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,19152,63,1.13 [0.87-1.47],0.3673841939493035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22626,72,1.25 [0.93-1.69],0.1457377655712131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22873,71,1.13 [0.91-1.40],0.2569681663512462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19667,61,1.22 [0.87-1.72],0.254311274085344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,19099,60,1.39 [0.89-2.16],0.145262816244775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,22198,70,0.44 [0.20-0.98],0.0450429316891808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,19667,61,1.14 [0.85-1.52],0.3886903129957905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,19090,59,1.00 [0.74-1.34],0.9858845759458116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELN,Elastin,19699,63,3.06 [1.70-5.49],0.0001865197200233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,22521,70,1.14 [0.80-1.61],0.4754496642758168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,19099,60,1.19 [0.69-2.03],0.5304759975126205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22198,70,1.19 [0.77-1.83],0.4326846683195244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,18193,57,0.57 [0.33-0.97],0.0396586193043358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,22897,73,7.29 [2.36-22.48],0.000550452667287
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,22587,67,0.98 [0.75-1.30],0.912536035153406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,22821,68,1.07 [0.78-1.49],0.665164634082201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,19200,61,1.21 [0.80-1.81],0.3650051848534278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,19591,60,1.07 [0.71-1.60],0.7593444874980467
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19099,60,1.20 [0.52-2.78],0.6666292732557353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,19099,60,1.20 [0.77-1.87],0.4084734769568192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22897,73,3.66 [2.07-6.46],7.888014270227598e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22729,72,0.78 [0.50-1.20],0.2589622568442629
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19200,61,2.03 [1.03-3.98],0.0394857452875822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21927,69,1.50 [1.17-1.92],0.0011503927038979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,19591,60,0.86 [0.53-1.42],0.565956939450871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22112,69,1.84 [1.36-2.49],7.38722703465304e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22222,70,0.32 [0.12-0.84],0.0203601544036156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22222,70,1.16 [0.52-2.61],0.7153714959021222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,19200,61,1.40 [0.97-2.04],0.0741073359701062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,19152,63,1.39 [0.76-2.55],0.2897129004998605
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,19152,61,0.75 [0.47-1.20],0.225150315487263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,22624,72,0.99 [0.80-1.21],0.9012784337756182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,19591,60,1.16 [0.74-1.83],0.5163864375503028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,22695,72,1.78 [0.94-3.34],0.0746646250349366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,22060,66,0.90 [0.63-1.30],0.5874693143966325
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,21820,70,2.01 [1.19-3.38],0.0085061526426436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,19288,62,2.13 [0.91-5.01],0.0831746958417705
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,22897,73,2.42 [1.11-5.27],0.0255750073267216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,22421,64,1.68 [0.84-3.38],0.1429024465479671
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,22222,70,1.15 [0.86-1.55],0.3474608878763193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,19320,61,0.73 [0.38-1.43],0.3652436780507228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,22585,70,1.20 [0.94-1.54],0.1403690753612849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,19200,61,1.26 [0.92-1.73],0.1443569507188513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22791,71,2.89 [1.61-5.21],0.0003998348539553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,22695,72,3.31 [1.42-7.69],0.0054185952711902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,22559,71,0.46 [0.15-1.41],0.1758299138241096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,22695,72,1.47 [0.62-3.49],0.3804925878418854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,22521,70,1.06 [0.86-1.30],0.5882532791899165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,19152,61,0.89 [0.62-1.28],0.5375631902042319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,19005,60,1.06 [0.51-2.22],0.8753293163205805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,22421,64,0.90 [0.68-1.20],0.4697198769824128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,19320,61,1.20 [0.60-2.38],0.6030060834928754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,19152,63,0.97 [0.56-1.67],0.90972626989557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19591,60,0.66 [0.34-1.28],0.2165626180630923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,19288,62,1.10 [0.90-1.36],0.3554206334356075
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,22481,70,1.15 [0.51-2.62],0.7389776894597033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19099,60,1.14 [0.69-1.87],0.6117479374852748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,22897,73,1.58 [0.84-2.98],0.1539234476430509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,22620,72,2.72 [1.50-4.91],0.0009171639594357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,19005,60,0.51 [0.27-0.96],0.0376086035384558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,19152,63,0.66 [0.37-1.17],0.1518158379408397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,19658,61,1.06 [0.79-1.43],0.7023039127154486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,19005,60,1.15 [0.68-1.94],0.6001738802829538
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,19152,63,1.30 [1.00-1.69],0.0496089580060079
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,19320,61,0.88 [0.41-1.89],0.7351490805463279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,19099,60,1.08 [0.74-1.58],0.6733288364304002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,19099,60,1.49 [1.05-2.12],0.0266863202040603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,22821,68,0.78 [0.31-1.94],0.5912589132469709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,19703,63,0.32 [0.17-0.60],0.0004027506276527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,19441,63,0.65 [0.39-1.06],0.0858868047301718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,22630,68,1.08 [0.74-1.57],0.7056437125578889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,19729,64,1.27 [0.71-2.27],0.420873613817683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,19611,63,0.65 [0.26-1.66],0.3706088143879957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,19729,64,0.39 [0.15-1.04],0.0593511261804782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,22690,72,1.17 [0.81-1.68],0.4080919819291982
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,22690,71,1.94 [0.94-3.98],0.0722348931945979
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,22657,70,0.71 [0.35-1.42],0.3304761203620765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,22649,70,0.46 [0.14-1.50],0.1952877112132101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",22620,72,1.37 [1.12-1.68],0.0026021522074291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",22626,72,1.06 [0.81-1.38],0.6887705391494052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",19699,63,1.07 [0.65-1.76],0.7815146139396377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",22897,73,1.08 [0.72-1.63],0.7087447228833642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,22752,66,0.83 [0.60-1.16],0.2783272472551694
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,22189,70,0.92 [0.62-1.36],0.6828586162472279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,22585,70,0.90 [0.61-1.32],0.576103283253504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,22626,72,1.12 [0.86-1.47],0.3938554703578617
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,19597,60,1.07 [0.74-1.55],0.7155678731018474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,19667,61,1.11 [0.97-1.27],0.139826253584473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,19591,60,1.21 [0.54-2.70],0.6444071566968699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,19200,61,1.12 [0.75-1.67],0.5775299325237236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,19699,63,1.17 [0.50-2.73],0.7251334067268888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,22521,70,1.32 [0.72-2.44],0.3691902276223257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,22591,71,1.06 [0.52-2.15],0.8822003966773899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,19597,60,1.15 [0.85-1.54],0.3630240342113533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,22897,73,1.61 [0.75-3.48],0.2228210840592218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,19152,61,1.19 [0.87-1.62],0.2824322588942157
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,22828,72,1.63 [1.11-2.38],0.0117869240757817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,22873,71,0.86 [0.49-1.50],0.5886752252637499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,19695,63,1.99 [0.97-4.10],0.0599925315506449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,19152,61,1.21 [0.81-1.82],0.3549827992359854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",22626,72,1.19 [0.91-1.56],0.2010576694819948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19699,63,1.40 [1.01-1.93],0.0425090593178264
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,22585,70,1.12 [0.72-1.75],0.6094339543559225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19667,61,0.90 [0.33-2.48],0.8347908161608524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,22630,68,1.08 [0.69-1.71],0.7324525738404022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22508,68,1.36 [0.89-2.08],0.1611324258359822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22112,69,0.96 [0.66-1.40],0.8185027639288235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22618,70,1.07 [0.70-1.63],0.762121266980418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,19662,63,0.98 [0.64-1.49],0.9137468509942184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,22497,70,0.58 [0.39-0.86],0.0063320066219095
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,22626,72,1.11 [0.69-1.78],0.6688068537609719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,22765,70,1.21 [0.78-1.86],0.3921569870504148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,22198,70,1.21 [0.82-1.77],0.3386564274250043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,22630,68,0.96 [0.66-1.41],0.8404269411888519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,22585,70,1.08 [0.80-1.47],0.6087760886844313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,22112,69,1.21 [0.88-1.68],0.2386045983966217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",19099,60,1.22 [0.88-1.69],0.2388580294989133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",19099,60,0.73 [0.44-1.20],0.218281974129951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,22112,69,1.07 [0.80-1.43],0.6662635678123136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,22112,69,0.99 [0.62-1.56],0.9517323544523492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,22649,70,0.76 [0.43-1.34],0.3425383835765359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,19259,62,0.80 [0.35-1.78],0.5787902683640753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19667,61,1.22 [0.90-1.65],0.1980252924577878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,19152,63,0.48 [0.20-1.18],0.1116433076891984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,19152,63,0.92 [0.54-1.56],0.7538004126933818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,22729,72,1.19 [0.91-1.56],0.1942201239528789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,22585,70,1.41 [1.05-1.90],0.0238508500048508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,19152,63,0.85 [0.47-1.56],0.6060063735589105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,22786,71,1.14 [0.96-1.35],0.1485914412802368
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,22792,70,1.22 [0.89-1.68],0.2163508803213437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,19152,63,0.83 [0.34-2.01],0.6820543278410229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,22198,70,1.46 [0.80-2.65],0.2162264937867034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,19152,63,0.58 [0.27-1.27],0.1745295327335854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,19005,60,0.89 [0.63-1.26],0.5031018015703006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,18967,60,1.00 [0.55-1.85],0.989256486682172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,22695,72,0.47 [0.25-0.89],0.0203942453249611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,19695,63,1.09 [0.68-1.76],0.7114323177881334
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,19658,61,1.50 [0.77-2.90],0.230004798352716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,22695,72,4.95 [2.18-11.23],0.0001295006366791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,19288,62,0.68 [0.43-1.08],0.1064732236372746
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,19703,63,0.99 [0.68-1.45],0.9595259440292626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,22060,66,1.05 [0.74-1.49],0.770976108134949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",19090,59,0.63 [0.41-0.98],0.0385987903650341
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,19099,60,0.78 [0.44-1.37],0.38534282558078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,22060,66,1.07 [0.80-1.44],0.6442822256451417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,22626,71,1.07 [0.82-1.40],0.6006485933798753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19667,61,1.04 [0.81-1.33],0.7781515131196359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22692,71,1.10 [0.92-1.33],0.2955504091959441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22470,65,1.25 [0.76-2.05],0.3857150134877842
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22470,65,1.04 [0.83-1.32],0.7254846958798575
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22011,65,1.01 [0.63-1.61],0.9776649900690432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,19597,60,1.03 [0.67-1.56],0.9080598057411114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,22112,69,1.07 [0.88-1.30],0.4782834939514578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22470,65,1.66 [0.77-3.54],0.1935062455202659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,22481,70,1.01 [0.37-2.77],0.9809284690314162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,22112,69,1.22 [0.66-2.27],0.5277118110831092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,22873,71,1.20 [0.63-2.29],0.5855592668532112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,22695,72,0.91 [0.49-1.69],0.7628105366251224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,22060,66,1.07 [0.79-1.46],0.6478267554218555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,22112,69,1.24 [0.67-2.27],0.4933158293829313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,19729,64,0.69 [0.27-1.71],0.4187666248277397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,19658,61,1.04 [0.61-1.77],0.881111497089817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19591,60,1.03 [0.51-2.05],0.9410941854270152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,19152,63,0.90 [0.68-1.19],0.4534380881504414
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,22587,71,1.50 [0.72-3.11],0.2743913206353566
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,22821,68,1.47 [0.72-3.02],0.2935038497931859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,22622,72,0.99 [0.88-1.11],0.802316608217361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,18967,60,0.96 [0.47-1.92],0.8975935516384552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,22060,66,0.72 [0.37-1.38],0.3184149563086178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,19152,63,1.52 [0.99-2.33],0.0560371038173243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,22585,70,1.12 [0.87-1.44],0.3647487977725548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,22112,69,0.88 [0.69-1.11],0.2777334458619019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,19099,60,1.05 [0.74-1.50],0.7689362515098606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,19152,61,0.88 [0.42-1.87],0.7490313616406226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,22395,65,2.50 [1.01-6.21],0.0485254912364347
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,19200,61,0.98 [0.68-1.43],0.9299146764779656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FST,Follistatin,22690,72,0.99 [0.65-1.49],0.9481601921904714
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,19200,61,2.55 [1.07-6.05],0.0341226554562148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,22587,72,2.08 [1.12-3.84],0.0198241410009215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,19630,61,1.41 [1.10-1.81],0.0060247813600174
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,22769,72,1.15 [0.88-1.51],0.3185947476752876
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,19288,62,1.60 [1.15-2.24],0.0057112877406836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FURIN,Furin,22695,72,0.83 [0.45-1.53],0.5472278865213627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,22080,68,1.41 [0.87-2.29],0.1644442012100888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19277,61,1.22 [0.89-1.66],0.2120561325669794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22821,68,2.04 [1.30-3.20],0.0018038459992125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",22470,65,1.00 [0.69-1.45],0.9986365710486812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",22825,71,1.06 [0.80-1.41],0.6658822840005576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,22198,70,1.19 [0.87-1.62],0.2750636337262619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,22595,68,1.04 [0.82-1.31],0.7493381692331107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,19152,61,1.26 [0.92-1.72],0.1517049996762072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,19090,59,0.82 [0.43-1.55],0.5349245373047742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,19591,60,0.63 [0.35-1.12],0.1175910963776405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19320,61,1.12 [0.80-1.55],0.510014822659942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19090,59,0.89 [0.58-1.36],0.588484488526922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,19005,60,0.43 [0.17-1.13],0.0869071645427978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,19152,63,0.55 [0.28-1.10],0.0918206966370687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19320,61,1.01 [0.63-1.64],0.9559464692587094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19200,61,1.02 [0.64-1.63],0.933180518849954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,19005,60,0.57 [0.33-0.99],0.0440324920653947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,22729,72,0.90 [0.64-1.26],0.5455708520091762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22521,70,2.88 [1.48-5.61],0.0018689169925902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22825,71,2.37 [1.08-5.22],0.0317648622457811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22198,70,1.84 [1.14-2.95],0.0121126486736997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19699,63,2.01 [0.95-4.26],0.0694852929969834
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,22521,70,0.99 [0.36-2.70],0.9833455391800868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,19099,60,1.41 [0.90-2.21],0.138581902263475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18866,61,1.35 [0.62-2.95],0.44867597546166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,19667,61,0.89 [0.34-2.32],0.8077901208274514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,19320,61,1.19 [0.81-1.74],0.3703936877277104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,22749,72,2.72 [1.23-6.03],0.0138570573008761
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,19099,60,0.96 [0.54-1.71],0.8963583271295459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,19658,61,1.00 [0.84-1.19],0.980510851691976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19005,60,0.98 [0.38-2.50],0.9653538640251624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19200,61,1.10 [0.81-1.50],0.5386570101595863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,19152,61,1.12 [0.71-1.75],0.6287049143113097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,19621,61,1.27 [0.89-1.80],0.184296730015062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,22198,70,1.11 [0.78-1.57],0.5778461052319961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,22060,66,0.80 [0.50-1.28],0.3452191266145042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,19099,60,1.36 [0.93-1.98],0.1154324796291735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,19729,64,0.50 [0.19-1.27],0.1432988103435097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,19658,61,1.11 [0.88-1.39],0.3887421430932554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,22112,69,1.09 [0.92-1.30],0.3023595440289138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18819,60,1.47 [1.02-2.14],0.0405443053178907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,19099,60,0.90 [0.52-1.58],0.7205296780435855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22521,70,1.50 [0.83-2.74],0.1818146487288985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,22897,73,1.89 [1.38-2.58],6.43904328164929e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,22626,72,1.01 [0.56-1.82],0.9658040718288452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,22060,66,2.25 [1.50-3.39],9.549958935752482e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,19699,63,1.09 [0.72-1.64],0.6914297413396122
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,22076,69,1.01 [0.64-1.59],0.9619166681856712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,22112,69,1.26 [0.92-1.74],0.1539415447926275
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22112,69,1.02 [0.87-1.21],0.7665552397210635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,22786,71,2.18 [1.07-4.45],0.0326616094789601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,22521,70,0.88 [0.33-2.36],0.796161096249913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,22404,65,1.98 [0.97-4.04],0.0601845039601899
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,19067,59,1.10 [0.74-1.64],0.6340233905068733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,22060,66,1.06 [0.78-1.44],0.7175511167064821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,19699,63,1.07 [0.76-1.50],0.7038222652841506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,19656,63,0.98 [0.59-1.62],0.935407339439643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22223,69,1.02 [0.55-1.92],0.9413529673296236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,22596,68,2.02 [1.45-2.81],3.372425705807692e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,22470,65,2.39 [1.07-5.32],0.033048743440163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,22591,71,1.06 [0.94-1.19],0.3591817258445395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,22112,69,0.92 [0.79-1.06],0.2247261290044849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,19288,62,1.33 [0.56-3.17],0.5201793229049254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,22060,66,1.27 [0.96-1.67],0.0963947346517449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,22626,72,1.01 [0.78-1.30],0.961184712688137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,19667,61,1.49 [0.89-2.48],0.1269091474218361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,19667,61,1.10 [0.81-1.52],0.5365857440053914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,19288,62,1.77 [1.09-2.87],0.0213498918558596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,19005,60,1.14 [0.75-1.73],0.5497485679564758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,19200,61,1.06 [0.68-1.64],0.799358509310745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,19658,61,1.49 [0.67-3.31],0.3253362966316818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,19597,60,0.99 [0.77-1.28],0.9510953505686452
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,19152,63,0.89 [0.52-1.53],0.6704240315925227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,19152,63,1.17 [0.91-1.51],0.2099539274764968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,19005,60,1.00 [0.67-1.47],0.9834405735089438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,21633,64,0.63 [0.28-1.39],0.2513795973353143
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,19245,62,2.05 [1.17-3.60],0.011889545643398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,22470,65,1.07 [0.63-1.84],0.8025068184413364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,19152,63,0.33 [0.13-0.81],0.0161679231449984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,22222,70,1.04 [0.73-1.48],0.8481639186190537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,22587,71,1.34 [0.75-2.40],0.3219415915725514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,19090,59,0.72 [0.33-1.53],0.3894399414073641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,22475,71,1.16 [0.81-1.66],0.4193119191155421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19288,62,1.08 [0.83-1.42],0.5617668254583713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22060,66,1.13 [0.75-1.71],0.5559683815174021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,19591,60,0.76 [0.46-1.26],0.2917727912279709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,19219,61,1.48 [1.01-2.15],0.0431773111140863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,19699,63,1.06 [0.76-1.48],0.7422019474588035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,22873,71,1.10 [0.73-1.66],0.6426064725688184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,19288,62,1.23 [0.86-1.75],0.2519085813606445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,19667,61,0.98 [0.74-1.30],0.8942786245144423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22112,69,1.23 [0.90-1.66],0.1924735912826169
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19152,61,0.63 [0.33-1.20],0.1612191019712784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,22630,68,1.15 [0.76-1.74],0.5062194878928679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,19200,61,1.21 [0.63-2.31],0.57276532095666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,19288,62,1.23 [0.63-2.37],0.544359122387301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,19667,61,1.05 [0.77-1.43],0.7588105673350382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,22821,68,0.64 [0.24-1.72],0.3780410960407647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22585,70,1.06 [0.86-1.31],0.6024451273570723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,19597,60,1.41 [0.86-2.30],0.1700363506267167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",19695,63,1.92 [1.34-2.75],0.0003714119978292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,22497,70,1.06 [0.55-2.07],0.8530410197138875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,19099,60,1.18 [0.82-1.71],0.3786173197547258
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21948,70,1.20 [0.96-1.50],0.1174626774008413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,19288,62,1.20 [0.60-2.43],0.6043279044551371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,22595,68,0.94 [0.74-1.20],0.6335016528483839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,22521,70,1.00 [0.86-1.17],0.9908892363217614
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,22825,71,1.10 [0.54-2.24],0.7962374326081676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,22470,65,0.73 [0.50-1.08],0.1140332797025682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,19591,60,1.54 [1.02-2.34],0.0419827686894613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,19597,60,1.30 [0.87-1.94],0.1931054169821824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,19703,63,1.26 [0.78-2.06],0.3471615421601489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19597,60,1.39 [0.95-2.05],0.0937817932650977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,22060,66,1.05 [0.51-2.19],0.8905790337254073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22007,66,2.30 [1.07-4.91],0.0318369135037033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,19090,59,0.74 [0.44-1.25],0.2608905724604702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,19667,61,0.85 [0.41-1.76],0.6656738309246677
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,19597,60,1.16 [0.78-1.73],0.4743579509814816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,22222,70,1.11 [0.81-1.52],0.5176691488523644
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,19591,60,1.83 [1.46-2.30],2.0167857179799365e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,22626,72,1.09 [0.93-1.29],0.2891102866352132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19699,63,1.14 [0.78-1.65],0.5030032580745346
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",19667,61,0.95 [0.53-1.69],0.853751475337657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19090,59,0.99 [0.63-1.54],0.956162173996056
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,22222,70,1.22 [0.85-1.74],0.2843985154842549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,22533,68,1.63 [0.67-3.94],0.2813905150720376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,19200,61,1.61 [1.05-2.48],0.0299283703608412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",22521,70,1.60 [1.19-2.14],0.0016481159502383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,18899,60,1.12 [0.83-1.50],0.464953731611357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,22112,69,1.10 [0.89-1.36],0.368085064279491
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,19634,63,0.60 [0.25-1.44],0.2544462400860144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",19583,62,1.10 [0.35-3.42],0.869794740765506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,22591,72,1.31 [1.05-1.63],0.0160203598748692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,22112,69,1.26 [0.99-1.61],0.0568618203110546
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,19099,60,0.95 [0.66-1.37],0.7989488424809073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,21924,66,0.72 [0.51-1.03],0.0693392223469657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,19658,61,1.14 [1.02-1.27],0.0178123268747005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19320,61,1.27 [1.00-1.61],0.0455601464193218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,19152,61,1.09 [0.80-1.48],0.5800423201637483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,22521,68,1.58 [0.84-2.97],0.1546515275404096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,19320,61,0.73 [0.50-1.07],0.1100613334563399
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,19099,60,0.85 [0.42-1.74],0.6613541322644796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,22733,71,1.27 [0.92-1.76],0.1404655838352082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",22222,70,1.09 [0.87-1.37],0.4577224948307832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,22873,71,0.61 [0.33-1.12],0.112031609286301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,22585,70,0.62 [0.42-0.91],0.0138371392416781
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,22222,70,1.13 [0.88-1.45],0.3434214593649772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,19005,60,0.66 [0.34-1.30],0.2326008614267954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19099,60,0.78 [0.48-1.26],0.3132077365874928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22753,71,1.13 [0.86-1.48],0.3878870039156132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,22825,71,1.32 [1.15-1.53],0.0001323573076066
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",22630,68,1.06 [0.80-1.40],0.6959099839239306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,22792,71,1.98 [1.47-2.66],5.353303335883297e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,22630,68,1.92 [1.08-3.41],0.0255248281743103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,22753,71,0.89 [0.67-1.19],0.4465767928358541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,22825,71,1.32 [0.95-1.83],0.0927303449888222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,19699,63,1.00 [0.79-1.25],0.975686127448365
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,19099,60,0.80 [0.44-1.45],0.4565091447788318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,22873,71,1.01 [0.69-1.48],0.94627322160874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,19152,63,0.50 [0.26-0.97],0.0392776223960751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,19090,59,0.90 [0.58-1.38],0.6267149734356976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,19597,60,1.16 [0.68-1.98],0.5798165300387254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,22796,71,1.14 [0.92-1.41],0.2387846829322141
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,19658,61,1.09 [0.75-1.58],0.6631440771797281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,22222,70,1.08 [0.76-1.53],0.6603483625216048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19288,62,4.13 [1.71-10.00],0.0016541974165052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,19658,61,1.19 [0.65-2.16],0.5725990555604262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,19699,63,1.79 [0.69-4.68],0.2338170156029758
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,22585,70,1.06 [0.82-1.38],0.6423563018119177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,22873,71,2.44 [1.42-4.20],0.0012688600792069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,19510,63,1.17 [0.49-2.79],0.7150649366189534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22112,69,1.19 [0.91-1.55],0.2017442399314049
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,19658,61,1.20 [0.87-1.66],0.2611806137517754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,19152,63,1.00 [0.69-1.44],0.9794234139269812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,19099,60,1.37 [0.77-2.42],0.2785679928707144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,19623,61,1.44 [0.96-2.18],0.0790837358608858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,19667,61,0.91 [0.52-1.61],0.7526255970497773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,22222,70,0.82 [0.38-1.77],0.6132852357430342
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19667,61,0.85 [0.40-1.80],0.6740084197288948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22519,70,1.30 [0.74-2.29],0.3685190960791844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22585,70,1.40 [0.69-2.84],0.3478591716110659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,22825,71,1.18 [0.75-1.86],0.4815580558064235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,19252,62,1.76 [1.13-2.73],0.0127313353348784
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19200,61,1.41 [0.91-2.17],0.1194765268937888
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19099,60,1.28 [0.79-2.06],0.3210874293804593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,18977,60,1.00 [0.60-1.67],0.987867308257386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22375,70,1.70 [1.12-2.60],0.0133931852901033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,22060,66,1.67 [1.19-2.33],0.0027122552041727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,19152,61,1.21 [0.93-1.58],0.1518504846672004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,22351,64,1.83 [1.18-2.82],0.0064547452953652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22157,70,1.03 [0.78-1.35],0.8286221414365977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19667,61,1.22 [0.78-1.91],0.3806327973920576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,22873,71,1.01 [0.76-1.34],0.958440798027226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,22112,69,0.72 [0.40-1.29],0.274079508954722
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,19416,61,0.94 [0.72-1.22],0.6520766924973271
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,19284,61,0.95 [0.73-1.23],0.7001895162689951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19200,61,1.19 [0.64-2.24],0.5829579724894732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,19611,63,1.28 [0.59-2.75],0.5301515920081503
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,19200,61,1.19 [0.90-1.57],0.2181903757983439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22521,70,0.87 [0.50-1.52],0.6266074538249838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22825,71,1.82 [1.09-3.05],0.0230527844904116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19152,63,0.81 [0.36-1.81],0.6012710159596035
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,19200,61,1.12 [0.86-1.44],0.3978051047532028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22585,70,1.17 [0.69-1.98],0.5687576724199794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19658,61,1.52 [1.06-2.18],0.0221021919797962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,19099,60,1.24 [0.79-1.93],0.3472956817203048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19200,61,1.14 [0.68-1.90],0.6201914742867083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,21958,66,0.77 [0.51-1.17],0.2180122988896755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,22695,72,1.12 [0.85-1.49],0.4114364856840282
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,19591,60,1.40 [0.74-2.67],0.3003607724656424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,22259,71,1.09 [0.79-1.51],0.5960693532101301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,22825,71,1.04 [0.58-1.85],0.9025600635013924
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22427,68,2.44 [1.23-4.83],0.0102936375515118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,19090,59,1.17 [0.92-1.50],0.2058809122814393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,19090,59,0.96 [0.53-1.74],0.897729647118017
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",22695,72,1.33 [0.96-1.85],0.0842532474113588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,22459,70,1.61 [0.67-3.86],0.2849743025235703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,22897,73,1.50 [0.58-3.84],0.4023446005417992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,22198,70,1.10 [0.84-1.43],0.488817464877783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,22507,69,3.16 [1.79-5.59],7.71965857152998e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,22897,73,1.58 [0.81-3.08],0.1797675344906894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,22897,73,1.47 [0.65-3.34],0.3531534952845905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,22585,70,1.40 [0.93-2.11],0.1084421569419065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,22626,72,1.57 [0.97-2.54],0.0645681635836142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,22521,70,1.26 [0.42-3.79],0.6805289782780931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,19320,61,0.79 [0.42-1.50],0.467937953179723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,22060,66,0.88 [0.54-1.43],0.5937718746629321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",19200,61,1.25 [0.89-1.76],0.1882997621162828
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,22873,71,0.48 [0.11-2.09],0.3260816727107881
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,22825,71,1.06 [0.67-1.67],0.8176762442567891
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19116,60,1.74 [0.99-3.06],0.0521415966979045
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19320,61,0.95 [0.60-1.52],0.8407314957442149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19320,61,0.81 [0.41-1.62],0.5522066049335707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,19597,60,0.82 [0.30-2.20],0.6906287188586351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,22198,70,1.03 [0.85-1.24],0.7920395438103991
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,22729,72,3.40 [1.29-8.99],0.0135141299898764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,22470,65,0.94 [0.61-1.44],0.7810722011617375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,22060,66,1.70 [1.14-2.53],0.0096342962763198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,19090,59,1.03 [0.71-1.50],0.8773009117700412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,22585,70,1.28 [0.76-2.14],0.3544990656362959
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,19099,60,0.48 [0.19-1.20],0.1171566230699215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,19152,61,1.02 [0.58-1.80],0.933720414823663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,19667,61,1.09 [0.73-1.61],0.6791580718967254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19090,59,0.71 [0.37-1.38],0.3166150263611479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19695,63,1.59 [0.63-4.00],0.3252429547259348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,22521,70,1.36 [0.60-3.11],0.4642888302985046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19099,60,1.21 [0.78-1.89],0.3960374739765291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,22630,68,1.53 [0.60-3.87],0.3699411808150844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,22858,73,1.14 [0.96-1.36],0.1405718779319385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,22858,73,1.20 [0.87-1.66],0.2715909785255765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,22687,71,0.43 [0.23-0.82],0.010833141461104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22333,66,1.43 [0.88-2.32],0.1464876784197453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,22503,69,1.07 [0.51-2.24],0.8645050491551978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,22897,73,3.54 [2.33-5.38],3.152230161003394e-09
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,22626,72,2.99 [1.83-4.89],1.1807557010768045e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,19152,63,1.15 [0.89-1.49],0.2948449821294602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,19099,60,1.21 [0.81-1.80],0.3516926407534703
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,19690,64,0.69 [0.21-2.26],0.5365914090954713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,19005,60,0.87 [0.63-1.21],0.4143113716813238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,19200,61,1.27 [0.73-2.19],0.401293816520875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,22521,70,2.45 [1.69-3.56],2.6054122862363908e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,22626,72,1.75 [0.90-3.41],0.0999403033572148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,19699,63,1.35 [1.03-1.78],0.0299898223462868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,22585,70,1.11 [0.88-1.40],0.3809820876143959
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,22112,69,0.90 [0.68-1.18],0.4297956835716028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,22198,70,1.05 [0.82-1.34],0.694791633420472
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,22198,70,1.03 [0.73-1.46],0.8679827793942856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,22729,72,2.57 [1.54-4.29],0.0003067345018912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,22198,70,0.91 [0.63-1.30],0.5951787113836337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,22521,70,1.16 [0.89-1.51],0.2603231983792091
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,22873,71,1.27 [0.86-1.86],0.2257279308471583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,22198,70,0.80 [0.45-1.42],0.4401698041454713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,19152,63,1.06 [0.59-1.88],0.8530893291227358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,22198,70,1.08 [0.73-1.60],0.6975390602254726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22341,72,2.68 [0.99-7.22],0.0516468528713488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,19090,59,0.73 [0.31-1.74],0.4830751067131766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,22585,70,2.34 [1.40-3.92],0.001176334244131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,22198,70,1.26 [0.69-2.31],0.459068194477316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,22873,71,1.07 [0.66-1.74],0.7733877795976959
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,22174,70,0.80 [0.47-1.38],0.430554836940852
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,22198,70,1.17 [0.89-1.53],0.25565740318404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,22198,70,1.40 [0.86-2.27],0.1804606493896971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,22198,70,1.04 [0.81-1.35],0.7361608124748018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,22630,68,1.21 [0.75-1.98],0.4336172988123787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,22290,68,1.57 [1.06-2.34],0.0259519371279685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,22545,72,1.21 [0.79-1.85],0.3884324628755354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,22687,71,2.63 [1.51-4.56],0.0005886606458413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,22873,71,2.31 [1.27-4.19],0.0060169525934879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,22323,64,0.93 [0.81-1.06],0.2957291132257102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,22060,70,1.51 [1.16-1.97],0.0024496495911432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,22198,70,0.92 [0.61-1.38],0.6894357798508612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,22097,70,1.21 [0.86-1.70],0.2712003405924132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,22596,68,3.18 [1.40-7.21],0.0055919419817461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,22590,71,5.14 [1.70-15.52],0.0037280837699523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,22630,68,0.67 [0.40-1.12],0.1257245727597103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,22828,72,1.56 [0.98-2.49],0.0634169761777859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,22198,70,0.74 [0.43-1.26],0.2704432715674663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,22585,71,1.28 [0.93-1.77],0.1339571897807837
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,22198,70,1.27 [0.63-2.52],0.5034028727935942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,22198,70,0.86 [0.55-1.36],0.5267200817245753
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,22198,70,0.64 [0.35-1.16],0.140411035947281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,19152,63,0.86 [0.47-1.56],0.6184430099404059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,19152,63,1.36 [1.02-1.82],0.0373383241379194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,19591,60,0.97 [0.66-1.41],0.863990452613846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,22198,70,0.84 [0.49-1.44],0.5247805091520372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,22198,70,1.02 [0.66-1.55],0.9448979279084492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,18935,60,0.58 [0.29-1.16],0.1223570279630816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,22455,71,1.79 [1.10-2.92],0.0201345363758196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,22198,70,0.72 [0.38-1.35],0.3011842122221405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,19591,60,1.19 [0.71-2.02],0.5054280772141635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,19005,60,0.84 [0.58-1.22],0.3722704980140777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,19152,63,1.38 [1.02-1.86],0.0349768061290243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,19075,61,1.44 [0.80-2.62],0.2273983905518984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,22585,70,1.70 [1.11-2.60],0.0141083621342428
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,22198,70,1.04 [0.60-1.79],0.8960408616687005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,22030,66,1.11 [0.60-2.03],0.7477746385782381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,19152,63,1.01 [0.66-1.54],0.9753996405124772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,19070,63,1.25 [0.93-1.68],0.1357207394744938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,22198,70,1.24 [0.65-2.36],0.5106339182671771
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,22198,70,0.94 [0.76-1.17],0.572435654468879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,22585,70,2.60 [1.72-3.93],5.5815132347764186e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,22198,70,1.03 [0.89-1.19],0.6922160342947172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,22585,70,1.46 [1.01-2.10],0.0435196617832778
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,22521,70,1.07 [0.81-1.41],0.6366338456743116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,22463,69,1.18 [0.63-2.21],0.6004302702964375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,22626,72,2.84 [1.25-6.48],0.0129010392394609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,22585,70,0.87 [0.63-1.22],0.4210363952497681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,22630,68,1.57 [1.03-2.39],0.0378733883040289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,19320,61,1.21 [0.86-1.70],0.2853661719050447
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22035,66,1.19 [0.84-1.70],0.3329504802908404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,19591,60,1.48 [0.96-2.28],0.0760640171597585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,22470,65,1.02 [0.71-1.46],0.9253958256410648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,19658,61,1.28 [0.84-1.96],0.2491302659701454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,19090,59,0.37 [0.13-1.01],0.0528873756645262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,22011,65,1.43 [1.00-2.04],0.0507112929285321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,19288,62,1.41 [0.90-2.21],0.1318569738269442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,22630,68,1.04 [0.62-1.74],0.8774465807813295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,22521,70,1.34 [0.92-1.95],0.1263868149340337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19200,61,1.19 [0.78-1.81],0.4245086438339268
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19667,61,1.03 [0.59-1.79],0.9196065010413412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22521,70,1.15 [0.93-1.43],0.20622107641651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,19658,61,1.30 [0.81-2.09],0.269014074129603
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,19591,60,1.14 [0.75-1.73],0.5490733487210072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,19597,60,1.14 [0.89-1.46],0.2941497466845855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,19152,63,0.63 [0.15-2.71],0.5394021327047905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,22435,65,1.00 [0.78-1.28],0.972086455637712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,22521,70,1.45 [1.02-2.08],0.0409342130430196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22222,70,1.11 [0.89-1.39],0.3664444566729995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,22198,70,1.11 [0.81-1.50],0.5190485745068003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,22585,70,1.14 [0.92-1.40],0.2321503260061178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21748,62,1.79 [1.01-3.19],0.0475034836968034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,22585,70,2.14 [1.33-3.45],0.00184004352977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,19695,63,0.87 [0.48-1.57],0.6425190193442043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,19457,60,1.03 [0.80-1.32],0.8206097402330764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,22585,70,1.38 [0.76-2.48],0.2853177839290194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,19288,62,0.99 [0.48-2.06],0.9888433351255932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,22630,68,3.37 [1.57-7.25],0.0018511074203999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,22585,70,1.00 [0.67-1.48],0.984006187860284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,19152,63,1.55 [0.86-2.77],0.1448220261754297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,22630,68,1.17 [0.59-2.29],0.6530600824044448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,22825,71,1.45 [0.39-5.42],0.5791333648560149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,19320,61,1.27 [0.86-1.86],0.2270928107629683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,22578,70,2.73 [1.32-5.63],0.0067221929179959
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,22112,69,0.63 [0.41-0.96],0.032903144203304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,22222,70,1.08 [0.89-1.31],0.4578706780353639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,22476,70,2.05 [1.00-4.19],0.0500724208461534
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,22695,72,1.50 [0.91-2.49],0.1157407387204105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,22198,70,1.11 [0.54-2.27],0.7810325247135895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,22825,71,1.78 [1.19-2.67],0.0053793943780961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,19695,63,3.62 [2.28-5.77],5.9492557045980624e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19729,64,0.65 [0.18-2.35],0.5157705231103524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22687,71,1.76 [0.98-3.14],0.0570928306314007
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19729,64,0.71 [0.28-1.80],0.4684063680496986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19591,60,1.25 [0.78-2.01],0.3480899188070719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,22585,70,1.05 [0.74-1.51],0.772019688283822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,19099,60,1.11 [0.77-1.60],0.575413411413163
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19200,61,1.12 [0.81-1.54],0.4848681130921543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19090,59,0.73 [0.38-1.39],0.3415002507908543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22060,66,1.21 [0.81-1.82],0.3496319534832385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,19005,60,0.40 [0.19-0.86],0.0185399488400296
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,22821,68,1.61 [0.73-3.55],0.2353051319553769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,19288,62,1.32 [0.84-2.07],0.2239943479792718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,22198,70,1.09 [0.77-1.54],0.6204141030397384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19005,60,0.97 [0.62-1.53],0.9081125303858232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,19597,60,1.03 [0.77-1.37],0.8553874398912573
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,22198,70,0.80 [0.48-1.33],0.3896184054699333
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22521,70,2.12 [1.27-3.55],0.0041941128069569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,19597,60,1.06 [0.84-1.35],0.623127060171339
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,19090,59,1.25 [0.88-1.77],0.2160197679355403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,19152,61,0.94 [0.67-1.32],0.7215244455744945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,22060,66,0.86 [0.52-1.41],0.544729199497313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,19295,60,1.48 [0.95-2.30],0.0814662922163907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,19152,63,0.75 [0.51-1.10],0.1351816261787632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,22695,72,0.40 [0.18-0.88],0.0222073445122088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,22060,66,2.63 [1.44-4.80],0.0017134605318736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,19005,60,0.64 [0.38-1.07],0.0883903055232094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,19200,61,1.62 [1.10-2.38],0.0138161820427232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,19658,61,1.47 [0.72-3.02],0.2907228588685139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,19320,61,0.95 [0.67-1.34],0.7627755494196713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,19320,61,0.64 [0.26-1.58],0.3318835756266337
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,19591,60,1.07 [0.72-1.60],0.7316950770061768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,19099,60,1.22 [0.67-2.21],0.5148513155549972
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,19090,59,1.04 [0.76-1.41],0.8080752614672199
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,19099,60,1.04 [0.85-1.28],0.700345530728423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,22521,70,1.16 [0.89-1.51],0.2653962452203073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19591,60,1.12 [0.85-1.49],0.4197591480544229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22112,69,1.02 [0.78-1.34],0.8734829432043099
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19597,60,0.96 [0.83-1.11],0.5900333453766178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22112,69,1.01 [0.85-1.20],0.8716033090794736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19005,60,1.16 [0.92-1.46],0.2197965011425373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,19090,59,0.85 [0.52-1.40],0.5199044300082583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,22060,66,1.60 [1.02-2.51],0.0393621995160359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,22649,70,0.97 [0.48-1.98],0.9430207661393492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,22626,72,0.49 [0.29-0.83],0.0081409804629406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,22060,66,0.93 [0.69-1.26],0.6434824796853298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,19090,59,1.40 [0.82-2.41],0.2218989768233475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,19667,61,1.16 [0.73-1.86],0.5242214717718718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,22385,70,1.17 [1.01-1.37],0.0421093179796555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,22622,71,0.98 [0.58-1.66],0.9358113481965684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,22471,71,1.60 [0.91-2.82],0.1057433441193955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,22112,69,1.00 [0.86-1.16],0.9821519247690276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,22123,69,0.88 [0.55-1.43],0.6072595645860811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,22825,71,1.32 [0.85-2.07],0.2162256118209869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,19565,59,0.86 [0.53-1.39],0.5318308411125859
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,19695,63,1.36 [0.98-1.89],0.0644165620201433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,22825,71,1.01 [0.72-1.43],0.9373170209860908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,22668,72,0.72 [0.37-1.43],0.3505491935577824
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,18766,60,0.83 [0.42-1.61],0.5728861539636558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,21866,70,1.43 [0.80-2.53],0.2263835580854332
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,19329,62,0.62 [0.35-1.10],0.1038999668046858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,22873,71,1.50 [0.87-2.59],0.1475031580512024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19090,59,0.63 [0.36-1.11],0.1091056716996025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,22873,71,1.38 [0.87-2.17],0.1687020127762627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,19152,63,0.71 [0.37-1.36],0.3026128215053229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,19658,61,1.07 [0.63-1.81],0.8115339843201212
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",21336,65,1.51 [0.89-2.57],0.1300503941047276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",19099,60,0.81 [0.40-1.62],0.5514850734669523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",22521,70,1.43 [1.15-1.80],0.0016638527870713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",22552,70,1.51 [1.15-1.99],0.0030443288747126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",22060,66,0.79 [0.49-1.27],0.3312722007637544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",19099,60,1.37 [0.83-2.25],0.2163008005137525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",19090,59,1.28 [1.01-1.62],0.0373672857563355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,22587,72,1.23 [0.86-1.75],0.2547749899515832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,22873,71,1.16 [0.74-1.82],0.5281950952384393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,22695,72,2.00 [0.97-4.12],0.0600652441475602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19699,63,1.12 [0.86-1.46],0.3906629956677286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,19554,60,1.11 [0.71-1.71],0.6503554878018329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,22626,72,1.20 [0.88-1.63],0.2538626543367668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,22521,70,1.48 [0.92-2.38],0.1050456723599357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22620,72,1.33 [0.78-2.26],0.29733103489222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22470,65,1.05 [0.85-1.30],0.6554672093732709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,19099,60,0.91 [0.55-1.50],0.7102739241434006
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,22729,72,1.22 [0.66-2.27],0.5254889499471835
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19200,61,1.72 [0.75-3.96],0.1995541382881915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,19145,62,1.00 [0.43-2.31],0.9932852511786716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,21929,60,0.45 [0.14-1.53],0.202798611690608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,22833,71,1.09 [0.73-1.64],0.6638163765725958
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,19591,60,1.06 [0.60-1.88],0.8316094747966943
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,22198,70,1.55 [1.09-2.20],0.014159704644659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,19591,60,1.10 [0.77-1.59],0.6012735120433949
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,22873,71,1.05 [0.80-1.39],0.7286806777078224
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,22521,70,1.08 [0.91-1.28],0.3862590252044957
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,19152,63,1.27 [0.96-1.69],0.0950863505776675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,22421,64,1.94 [1.08-3.50],0.0270750436789167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,22687,71,1.13 [0.79-1.62],0.4981189556024121
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,22821,68,1.00 [0.73-1.36],0.993740066037766
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,19703,63,0.61 [0.26-1.44],0.2620730127934602
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,19667,61,1.24 [0.90-1.71],0.1805167724338642
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,21919,68,1.12 [0.64-1.96],0.6838698448299533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,19695,63,0.47 [0.26-0.85],0.0125300068594674
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,22685,70,1.14 [0.76-1.69],0.5257886786932874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,19667,61,1.14 [0.89-1.48],0.2999537258435454
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,19699,63,1.20 [0.84-1.71],0.316574336005486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,22786,71,1.72 [1.14-2.57],0.008908847474956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,18626,59,0.86 [0.59-1.26],0.4476622995931483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,19090,59,0.76 [0.51-1.14],0.1835891350379735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,19667,61,1.03 [0.51-2.10],0.924336412797177
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEP,Leptin,22626,72,0.81 [0.58-1.12],0.2015381284653693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,22626,72,1.59 [0.86-2.95],0.1421815244459927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,19667,61,1.64 [1.12-2.41],0.0110529897251519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,22626,72,1.48 [0.81-2.71],0.1968422566515681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,22679,72,1.51 [0.76-2.99],0.2412238147884061
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,19729,64,1.87 [1.05-3.33],0.0341640809777988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,22620,72,1.56 [1.09-2.24],0.015892882474916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,22588,71,0.85 [0.49-1.47],0.5613797477027966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,22821,68,0.93 [0.65-1.34],0.7012302641622706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,22621,71,2.05 [1.12-3.76],0.0203216997787262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,22729,72,1.01 [0.56-1.80],0.977817249919087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,22112,69,1.22 [0.99-1.50],0.0617138668382077
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22654,72,1.24 [0.89-1.73],0.2045771040262222
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,22060,66,0.86 [0.54-1.37],0.5186615837223805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,22585,70,2.20 [1.00-4.87],0.051245472688512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22630,68,1.17 [0.63-2.16],0.6126783696186748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19695,63,0.91 [0.79-1.04],0.1630054132673878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19099,60,1.08 [0.69-1.68],0.7348412957322226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22591,71,1.16 [0.60-2.27],0.656523490711008
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19699,63,0.97 [0.70-1.34],0.866770323514291
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22897,73,1.45 [0.68-3.10],0.3393974919395525
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22789,72,1.47 [0.79-2.73],0.2281889294919432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22198,70,0.91 [0.56-1.49],0.7085041561777659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22897,73,1.24 [0.91-1.69],0.1809801280560432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,19200,61,1.06 [0.71-1.59],0.7597343137256102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,19554,60,1.10 [0.77-1.59],0.5934856061468409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,19658,61,1.81 [0.83-3.96],0.1364202048580286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,19667,61,1.10 [0.56-2.15],0.7764712715875945
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,19090,59,0.92 [0.61-1.40],0.7002519704646359
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",19200,61,1.07 [0.80-1.42],0.6508061143130648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),19235,62,1.04 [0.90-1.19],0.6092183838729388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,22521,70,1.15 [0.75-1.77],0.5091933950104364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,22626,72,0.92 [0.59-1.44],0.7253121365150316
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,21919,64,1.34 [0.94-1.92],0.1096421250142894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,19099,60,1.21 [0.84-1.75],0.3125823708731515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19099,60,1.08 [0.75-1.55],0.674558579822867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19152,61,1.13 [0.73-1.75],0.5787085899079649
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,19729,64,0.32 [0.14-0.73],0.0065423323297765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22753,71,1.05 [0.57-1.94],0.8764900486575936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19077,63,0.46 [0.17-1.27],0.1331538707220053
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,22521,70,1.26 [0.57-2.77],0.561347224869619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,22626,72,1.03 [0.57-1.84],0.9326845945826636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,19152,61,1.33 [0.79-2.23],0.2869227253960877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,19152,61,0.91 [0.67-1.24],0.5587222669951752
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22821,68,0.93 [0.63-1.37],0.7080249191012751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,22521,70,1.40 [0.84-2.33],0.2005826917963022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,19597,60,1.31 [0.73-2.34],0.3709322837255975
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,19152,61,0.49 [0.28-0.87],0.0146781175146775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,19699,63,1.25 [0.78-2.01],0.3541671014408916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19591,60,1.14 [0.70-1.87],0.5953858558811167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,22198,70,0.89 [0.51-1.55],0.66947731733909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19152,61,0.68 [0.34-1.36],0.2763775860514396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19667,61,1.54 [0.73-3.25],0.2605078197727146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,22112,69,0.99 [0.68-1.46],0.9711008676011144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19320,61,1.21 [0.98-1.49],0.0735368117190818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,22585,70,1.04 [0.62-1.76],0.8716523128757971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,22585,70,1.28 [0.77-2.12],0.3413178043208108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,22825,71,1.08 [0.75-1.54],0.6812046279459406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,19591,60,1.59 [1.07-2.37],0.0225372986873989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,22897,73,3.54 [2.02-6.20],1.0495554101610414e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,22112,69,1.30 [0.93-1.81],0.1250958596985039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,22517,71,2.71 [1.41-5.22],0.0028878315218304
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,22198,70,1.32 [0.87-2.00],0.1859390873927797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,19591,60,1.39 [0.92-2.10],0.1169202826101816
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LXN,Latexin,22367,65,0.95 [0.68-1.34],0.77980358634299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,22518,71,0.74 [0.41-1.33],0.3088828219768658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,22585,70,2.73 [1.50-4.95],0.0009728435293418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,22406,70,1.81 [0.87-3.75],0.1105603898608114
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,22470,65,1.51 [0.85-2.67],0.163176782398971
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,22112,69,0.70 [0.43-1.15],0.1617327696196257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,22521,70,1.09 [0.84-1.40],0.5152900236244798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,22060,66,1.04 [0.75-1.44],0.8206949726835064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,22508,72,1.51 [0.83-2.75],0.1754828090136769
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,22112,69,1.58 [1.19-2.11],0.0017862685464704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,19090,59,0.91 [0.70-1.18],0.4638704989115494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19152,61,1.16 [0.95-1.43],0.1543774845899345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19729,64,1.82 [0.55-5.97],0.3260864592716382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19005,60,0.75 [0.34-1.63],0.4657285072272917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,19288,62,1.20 [0.86-1.69],0.2826297206759636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,19200,61,1.09 [0.62-1.90],0.7751851114810564
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22385,64,1.20 [0.83-1.74],0.3327214043090588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,22112,69,1.15 [0.70-1.87],0.5791922634299427
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,19152,61,0.85 [0.51-1.44],0.5520934556443311
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,19320,61,1.17 [0.87-1.58],0.2878083006323446
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,22112,69,0.97 [0.62-1.53],0.9081475863845794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,19699,63,2.13 [1.11-4.08],0.0230679331600802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,19591,60,1.51 [0.99-2.30],0.0560068770388191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19200,61,1.44 [0.54-3.85],0.4658008010656426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,19699,63,1.46 [0.97-2.20],0.069153683847526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19005,60,1.01 [0.62-1.65],0.9696816986010868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,22729,72,1.04 [0.87-1.24],0.6913299655100817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,22695,72,1.33 [0.62-2.86],0.4571748878550207
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,19099,60,1.29 [0.92-1.80],0.1421585720836707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19090,59,0.80 [0.36-1.79],0.5899507584022087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19099,60,1.21 [0.91-1.60],0.189048043114097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,19658,61,1.14 [0.68-1.92],0.6202102506201683
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19597,60,1.22 [0.84-1.77],0.3035517822669344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22585,70,1.06 [0.86-1.31],0.6076938070741817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22112,69,1.05 [0.85-1.30],0.6552348192818322
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22421,64,1.08 [0.88-1.32],0.4525121693045482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,19005,60,1.29 [0.83-2.01],0.2640302400665485
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,22585,70,1.39 [0.85-2.26],0.1903434974409378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,19320,61,1.16 [0.83-1.61],0.38961102301443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,19005,60,0.95 [0.79-1.14],0.5752446980119159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,22060,66,1.09 [0.72-1.66],0.6811807581333214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,22626,72,1.26 [0.57-2.78],0.573235746214661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",19245,62,1.22 [0.92-1.62],0.1605589518026679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,22421,64,2.06 [0.79-5.37],0.1418137549654064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,22662,72,2.12 [1.06-4.23],0.0329545412475868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,22435,65,0.88 [0.43-1.79],0.7309506460395961
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,22112,69,1.05 [0.83-1.32],0.6876771481821378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MAX,Protein max,22060,66,1.06 [0.86-1.31],0.5912304993240055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,22897,73,1.01 [0.67-1.54],0.9557601583587702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,19441,63,1.02 [0.81-1.28],0.8613762055607385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,22687,71,1.73 [0.99-3.03],0.0550913877745172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19667,61,1.25 [0.77-2.05],0.36457478699611
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,19152,63,0.92 [0.70-1.20],0.5211556793291183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,22529,72,1.14 [0.71-1.85],0.5830761486657052
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,19597,60,0.87 [0.32-2.34],0.7839944652763987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22470,65,1.18 [0.87-1.62],0.2890552110169757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",19581,62,1.35 [0.78-2.35],0.2855884102710524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDK,Midkine,22636,72,1.04 [0.70-1.54],0.8472667965687678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,19152,61,1.18 [0.54-2.58],0.6758991353159935
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19200,61,1.06 [0.81-1.38],0.6915208703954084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,22112,69,1.05 [0.79-1.39],0.7254575097389073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,19099,60,1.06 [0.66-1.71],0.801277423213894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,22620,72,1.06 [0.61-1.86],0.8244016374141065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,19099,60,0.73 [0.32-1.71],0.4741839086572583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,22828,72,1.61 [0.58-4.47],0.3570733612905374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,19699,63,0.49 [0.21-1.11],0.0866589376583236
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,19288,62,0.55 [0.19-1.60],0.2700949874734585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,19597,60,1.15 [0.82-1.62],0.4241800409012
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,22626,72,0.94 [0.80-1.11],0.4851921314549211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,22620,72,0.93 [0.42-2.05],0.8624715970922742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,22873,71,1.71 [0.78-3.75],0.1799737056350241
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,22630,68,1.02 [0.85-1.22],0.8206414267504152
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,22682,71,1.50 [0.54-4.19],0.4372653788191999
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,22060,66,0.66 [0.30-1.43],0.2914370793179799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22585,70,1.01 [0.78-1.31],0.9363349827572276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,22786,71,1.22 [0.84-1.77],0.2892649278107497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,22222,70,0.74 [0.45-1.20],0.2200817923266031
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,19152,61,0.90 [0.60-1.34],0.5917777752565543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19288,62,2.00 [0.94-4.26],0.0725367783922706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,22897,73,1.26 [0.76-2.11],0.3694941610572314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,22630,68,1.32 [0.81-2.16],0.2695682027590791
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,22690,72,1.09 [0.86-1.40],0.47696939469243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,22585,70,1.06 [0.89-1.27],0.5044454981236318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,22695,72,0.79 [0.44-1.42],0.4322721904320298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,19152,61,1.09 [0.77-1.53],0.6404406452247822
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22585,70,1.12 [0.95-1.33],0.1911288817644423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,22600,68,1.11 [0.81-1.51],0.5346851141214625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,22198,70,1.30 [0.86-1.96],0.2099946072362498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19591,60,1.07 [0.85-1.35],0.5685410820744796
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,19658,61,1.16 [0.89-1.52],0.2822013493503087
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,22470,65,1.00 [0.80-1.26],0.9859990935321608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,19152,63,0.79 [0.40-1.59],0.5138299595913172
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,19005,60,0.90 [0.61-1.32],0.5833314329904375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,22585,70,0.84 [0.66-1.07],0.1527165316739871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,22521,70,1.53 [1.23-1.92],0.0001780423163764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,21755,66,0.94 [0.74-1.19],0.6148169865622735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,22589,72,1.18 [0.83-1.66],0.358960514451368
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,22645,71,1.16 [0.77-1.73],0.479593843758329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22060,66,1.31 [0.67-2.56],0.4304302223374252
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,19699,63,0.96 [0.58-1.58],0.8724833323318044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,22630,68,1.01 [0.65-1.57],0.9753084226959744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,22181,70,1.79 [1.14-2.82],0.0120759470392497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,22781,68,0.99 [0.74-1.33],0.9670411801732356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,22589,68,1.01 [0.71-1.44],0.9698683046583468
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19099,60,1.15 [0.70-1.87],0.5841526808275685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,19152,61,0.80 [0.49-1.30],0.367573600958032
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,19320,61,0.60 [0.32-1.16],0.1296866352800619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,22591,72,1.06 [0.88-1.29],0.5371955898528735
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,19288,62,1.43 [1.01-2.02],0.0424583343094168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,22825,71,0.83 [0.44-1.58],0.575317107246849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,19658,61,0.73 [0.28-1.92],0.5198894184190104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,19320,61,0.66 [0.32-1.35],0.2543824001374846
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,19005,60,0.84 [0.41-1.72],0.6364802252650317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,19005,60,0.95 [0.68-1.33],0.7738740263054833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,22222,70,1.12 [0.85-1.47],0.4051096222635004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,22521,70,1.16 [0.91-1.48],0.2269683837734315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22690,72,0.95 [0.72-1.24],0.6870472286582691
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,22630,68,0.92 [0.58-1.47],0.7404950906320897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,19548,60,1.34 [0.82-2.20],0.2483961134986382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,19703,63,2.62 [1.22-5.64],0.0139191606182272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,19152,61,0.86 [0.60-1.22],0.396445968134825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",19099,60,0.59 [0.27-1.29],0.1850825222476255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",19667,61,1.38 [0.90-2.10],0.1361452347007042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",22060,66,1.17 [0.54-2.52],0.6957843107448864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",18977,60,1.26 [0.49-3.28],0.634441462216317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19667,61,1.01 [0.72-1.41],0.9568198929788144
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",19152,63,1.16 [0.55-2.43],0.6938115725637954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,22490,70,0.96 [0.66-1.41],0.8486574502832541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,19152,61,1.35 [0.78-2.35],0.2815820062300065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,22537,71,1.15 [0.85-1.56],0.3521445173928423
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,22821,68,1.73 [1.08-2.78],0.0226826591024736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,22695,72,1.06 [0.79-1.41],0.7105185195334068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,19390,62,1.36 [0.81-2.29],0.2473189418042724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,22222,70,0.89 [0.59-1.36],0.5922403313180209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,19152,63,1.09 [0.84-1.42],0.5205031928211492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19658,61,0.82 [0.29-2.27],0.7004489768379618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19320,61,1.06 [0.85-1.33],0.5825866457263776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",19597,60,0.99 [0.75-1.32],0.9650382740873718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,22222,70,0.87 [0.44-1.72],0.6844358638517651
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,19099,60,1.41 [1.10-1.79],0.0056422185738903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,19597,60,1.18 [0.94-1.47],0.1485707662330239
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,19591,60,1.09 [0.85-1.40],0.4964486515818244
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,19320,61,1.50 [1.08-2.10],0.0161773489485797
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,22060,66,1.45 [0.95-2.21],0.0842415988116453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,22521,70,0.98 [0.88-1.10],0.7769163942052988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,19695,63,1.04 [0.80-1.35],0.767098902512173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,19005,60,0.90 [0.50-1.62],0.7166766130444729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,22198,70,1.43 [1.13-1.83],0.0034257086419092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,19288,62,1.50 [0.69-3.30],0.3084666632007757
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",19699,63,0.91 [0.62-1.34],0.6363667251977942
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",19200,61,0.96 [0.71-1.31],0.810112755232134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19667,61,1.14 [0.82-1.58],0.4415538068943072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,19699,63,1.11 [0.87-1.41],0.3966389406338604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,19099,60,1.27 [0.83-1.95],0.2751014435859775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,19005,60,0.64 [0.32-1.26],0.1925914499711227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,19695,63,1.10 [0.89-1.37],0.3610954428806233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19099,60,0.79 [0.39-1.60],0.5170472020660692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,19200,61,0.90 [0.63-1.30],0.5907106264261966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,19200,61,1.11 [0.72-1.72],0.6294327183436934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,19152,61,0.82 [0.60-1.13],0.2302729772792536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19152,61,1.16 [0.71-1.92],0.5491040000178751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,19667,61,0.97 [0.49-1.92],0.919619618922054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,22198,70,1.01 [0.73-1.39],0.95185631211037
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,22630,68,1.12 [0.70-1.80],0.6243401049870709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,19090,59,1.12 [0.69-1.80],0.6516134889091234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,19099,60,1.16 [0.70-1.93],0.5677173422768743
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,19288,62,0.90 [0.69-1.19],0.4617756596760934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,22701,72,0.88 [0.59-1.33],0.5539242701066818
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,22112,69,1.26 [0.87-1.82],0.2124590885129297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,19099,60,1.11 [0.69-1.81],0.6615954088927716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,19152,61,1.03 [0.83-1.26],0.8110266564921134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22365,65,1.02 [0.70-1.49],0.9128783719446892
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,19591,60,1.38 [0.94-2.03],0.1013357701361594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,22626,72,0.86 [0.58-1.27],0.4509213801589574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,19111,61,0.79 [0.47-1.32],0.3632795052284626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,19163,61,1.17 [0.76-1.79],0.4764457261716147
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19288,62,3.63 [1.25-10.49],0.017363555705555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,22112,69,0.96 [0.65-1.43],0.8588452568515808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,19569,60,0.89 [0.50-1.61],0.7103717687571398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,19658,61,1.44 [0.78-2.64],0.2437560408363167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",19667,61,1.56 [0.92-2.65],0.1002470435783543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,22695,72,1.31 [0.60-2.87],0.4939215179520645
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,22198,70,0.96 [0.64-1.45],0.8605019497228127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,22687,71,0.83 [0.39-1.77],0.6350799891798257
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,22630,68,2.16 [1.02-4.59],0.0447138488297526
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,22821,68,0.77 [0.44-1.35],0.3580391689173618
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,22557,70,1.02 [0.81-1.30],0.8459541007740237
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,22729,72,1.06 [0.87-1.29],0.5557708929288492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,22198,70,0.92 [0.58-1.44],0.7016221208984581
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,22551,69,1.27 [0.71-2.28],0.4154353507352175
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19597,60,2.81 [1.47-5.34],0.0016689888650571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,22825,71,1.42 [0.68-2.95],0.3456679848610139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,22060,66,1.13 [0.87-1.47],0.3481151142535361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19591,60,0.71 [0.43-1.19],0.194247799698984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19118,63,1.32 [0.67-2.57],0.420860848772511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19597,60,0.95 [0.72-1.25],0.7010428498730028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22112,69,0.89 [0.65-1.22],0.4713306323223323
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,19099,60,1.35 [0.80-2.26],0.2566287306555749
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,19099,60,1.08 [0.76-1.54],0.6718926809567215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,19152,63,1.14 [0.54-2.38],0.7331837746790064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,22591,71,2.55 [1.31-4.97],0.0060682745657839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,22695,72,1.19 [0.60-2.34],0.6232608980003855
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19152,63,1.29 [0.77-2.16],0.3395252721322539
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,19152,63,1.74 [1.08-2.81],0.0239261658423448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,21981,66,1.21 [0.72-2.03],0.4793859521343167
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,19320,61,0.91 [0.64-1.29],0.6040546109484384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,22695,72,0.85 [0.52-1.39],0.5196110456715132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,22729,72,2.03 [0.99-4.17],0.0529107339416162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,19591,60,0.85 [0.65-1.11],0.2440821952268874
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,19667,61,1.86 [0.73-4.75],0.1918899355951965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,19703,63,1.22 [0.87-1.71],0.2515360572988265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,22873,71,5.28 [2.73-10.20],7.725137967892822e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,19152,63,1.11 [0.85-1.45],0.4401177038803254
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22585,70,1.13 [0.91-1.41],0.2769859559431841
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22198,70,1.12 [0.79-1.59],0.5232652985665902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,19200,61,1.12 [0.81-1.56],0.4820321481500371
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,19667,61,1.13 [0.71-1.82],0.6023868720274509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,19099,60,1.11 [0.79-1.55],0.5581428853187569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,19320,61,1.12 [0.77-1.62],0.5507013257641018
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,22112,69,1.21 [0.80-1.84],0.3664890067997923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19597,60,1.01 [0.79-1.29],0.9310590306804488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,19099,60,1.33 [0.96-1.85],0.0883554493701637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,19099,60,0.99 [0.53-1.86],0.9755800627559916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,22470,65,2.01 [0.38-10.56],0.411660740102676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,19699,63,1.44 [0.76-2.73],0.2662942654003916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,19658,61,0.75 [0.23-2.44],0.6329681979212307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,18807,60,2.17 [0.96-4.87],0.0609994906454179
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,22609,70,1.49 [0.89-2.47],0.1270258775737273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,22630,68,1.02 [0.77-1.34],0.9067714908466789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,22112,69,0.85 [0.55-1.34],0.4906818601122419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,19200,61,1.03 [0.62-1.72],0.8949862754555947
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,19630,63,1.19 [0.86-1.65],0.2842373263256527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,19152,61,1.05 [0.76-1.46],0.7593170545440685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,19090,59,0.61 [0.31-1.19],0.1490345853146436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,19152,63,0.71 [0.22-2.27],0.5664847868550829
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,22662,72,1.57 [0.74-3.32],0.2432534203403379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,19520,60,1.13 [0.81-1.58],0.4777388344010741
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22470,65,1.22 [0.96-1.54],0.10124211342126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,19005,60,0.56 [0.25-1.26],0.1618785389800129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19667,61,0.95 [0.65-1.39],0.7957810056054051
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,22630,68,2.55 [1.24-5.23],0.0107051061809374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,19099,60,0.93 [0.72-1.19],0.5558202722745627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",22060,66,1.40 [0.92-2.14],0.1179591848063802
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",19099,60,1.16 [0.63-2.15],0.6310156896608098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",22060,66,1.20 [0.83-1.72],0.3363454125046866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,22897,73,3.85 [1.10-13.42],0.034728878498156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,19695,63,1.07 [0.34-3.39],0.9042774865621512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,22897,73,2.13 [1.19-3.80],0.0109855730981734
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,19358,61,1.63 [0.86-3.10],0.1333807230367193
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,22626,72,1.72 [0.93-3.16],0.0823919776135939
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,19152,63,0.52 [0.24-1.12],0.0932506215427436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,19152,63,1.08 [0.87-1.33],0.5033244682235695
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,19699,63,1.37 [0.82-2.29],0.2346942624127306
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22222,70,0.96 [0.82-1.13],0.6513965202321823
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,22585,70,1.41 [0.90-2.22],0.135108736253976
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,19099,60,0.98 [0.53-1.83],0.9529116903404076
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,22112,69,1.09 [0.86-1.37],0.4803180399743854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,22630,68,2.21 [1.36-3.61],0.0014519177357378
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,19695,63,1.81 [0.86-3.81],0.1152323697180917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,22626,72,1.85 [1.13-3.05],0.0152865937698562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,22825,71,1.33 [0.96-1.85],0.0861160507587415
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,22626,72,2.11 [1.07-4.16],0.0319960150391069
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,19703,63,1.14 [0.87-1.48],0.3464226343063363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,19667,61,0.85 [0.39-1.86],0.6891798263648155
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,22730,71,2.63 [1.38-5.03],0.0034017020856352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,22630,68,2.29 [1.24-4.22],0.0079576286309515
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,22198,70,1.11 [0.75-1.64],0.605194175498477
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,19152,61,0.96 [0.48-1.94],0.9125873324537278
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,22821,68,0.96 [0.70-1.33],0.8255857992482689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19699,63,1.16 [0.84-1.61],0.3731419286670804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,19658,61,1.18 [0.59-2.34],0.640904242711788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,22555,70,1.09 [0.86-1.39],0.4764952328238697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,22695,72,1.57 [1.17-2.13],0.0030553563207654
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,22585,70,0.76 [0.41-1.38],0.3673956866233405
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,22112,69,1.23 [0.82-1.83],0.3195255162185185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,22626,72,1.31 [0.58-2.96],0.5170092029748922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,22821,68,0.55 [0.21-1.45],0.2264871513350558
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,22626,72,1.13 [0.93-1.38],0.22190532595019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,22585,70,1.02 [0.80-1.32],0.8563927622789607
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19591,60,1.02 [0.80-1.31],0.8677604903999938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,22783,70,1.18 [0.67-2.09],0.5619982993664986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,22873,71,1.08 [0.77-1.52],0.6414621015659678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19200,61,1.46 [0.71-3.02],0.3018256761024723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19099,60,0.81 [0.47-1.40],0.4567938995997194
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,19561,60,1.17 [0.88-1.54],0.2772992821599149
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22521,70,1.19 [0.84-1.68],0.3218884990698293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,22630,68,1.10 [0.73-1.67],0.6421534924540955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,19152,63,1.19 [0.88-1.60],0.2534975658432289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,19099,60,1.04 [0.51-2.12],0.9121041512286744
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,19099,60,1.42 [0.90-2.25],0.1353153190647787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,22060,66,1.01 [0.56-1.83],0.9677215640405386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,19152,63,0.69 [0.31-1.52],0.3551065534333369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,22399,65,1.05 [0.74-1.48],0.7816255579647117
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,19667,61,2.65 [1.73-4.05],7.589421818389887e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,22030,66,0.94 [0.63-1.41],0.7704782479645954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,19320,61,0.58 [0.34-1.00],0.0500567483668643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,19597,60,1.12 [0.79-1.59],0.5224517157921901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,22521,70,1.14 [0.60-2.18],0.6903302107618345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,22630,68,1.05 [0.62-1.77],0.8642724985696583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19320,61,0.95 [0.63-1.42],0.7874384016598727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,18561,59,1.04 [0.85-1.29],0.6812915466516263
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,22406,70,1.08 [0.76-1.53],0.6712037577930585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,22729,72,1.57 [0.95-2.59],0.0792699705113105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,22521,70,1.08 [0.77-1.50],0.656470313042202
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,19090,59,0.87 [0.51-1.48],0.6021451309519879
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,19658,61,1.18 [0.94-1.48],0.1650681460750597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,19200,61,1.46 [1.04-2.04],0.02753554361214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,22521,70,1.40 [0.98-1.99],0.0644699789878838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,19661,64,0.70 [0.34-1.43],0.3258987561560653
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,19658,61,0.66 [0.31-1.43],0.2924242898728441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,22662,72,1.44 [0.77-2.70],0.25252378361709
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,22481,69,1.01 [0.75-1.36],0.9625265777341132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,22730,71,3.91 [1.67-9.17],0.0017244691974081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,19152,61,0.91 [0.48-1.70],0.7602536972645995
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,19090,59,0.76 [0.43-1.33],0.3313679980709377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,19597,60,1.11 [0.73-1.67],0.632866181535578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,19667,61,1.38 [0.95-2.01],0.0951844930723838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19200,61,0.94 [0.65-1.36],0.7411893867974245
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,22821,68,1.10 [0.94-1.29],0.2408895365249522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,22511,72,1.35 [0.79-2.30],0.27758227517956
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,19099,60,1.14 [0.77-1.70],0.5048491874639025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,22198,70,0.71 [0.44-1.14],0.1590269227090253
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,22030,66,0.92 [0.68-1.25],0.5946209892052838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,22470,65,0.90 [0.72-1.11],0.3219580617488514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19667,61,0.92 [0.73-1.17],0.5073828543591501
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19320,61,1.10 [0.67-1.79],0.715746597347817
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22222,70,1.04 [0.71-1.52],0.8502221541295191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,19200,61,0.90 [0.51-1.61],0.7303582489289598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18967,60,1.20 [0.78-1.85],0.4121243449410379
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,22060,66,1.11 [0.79-1.56],0.5386414817416978
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,19152,63,0.85 [0.44-1.64],0.6241935669633055
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,19494,60,1.43 [0.64-3.17],0.3831641910392238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,19658,61,2.37 [1.43-3.91],0.0007589661871916
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,19099,60,1.21 [0.95-1.56],0.1280721820982409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,22767,72,6.60 [2.95-14.76],4.275391380019045e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,22630,68,0.91 [0.42-1.98],0.8077540977561178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,22198,70,1.90 [1.24-2.90],0.0031413065005509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,19320,61,1.12 [0.83-1.51],0.4648526140463582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,22630,68,1.06 [0.71-1.58],0.7769385652913497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,22585,70,1.07 [0.76-1.51],0.7027388863279939
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,19288,62,1.56 [0.96-2.52],0.0698968145713765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,19005,60,1.22 [0.54-2.75],0.6240377942292106
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,22060,66,1.34 [0.89-2.01],0.154721699781977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19597,60,1.06 [0.47-2.39],0.882742641847321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,19090,59,0.98 [0.74-1.32],0.9191920684072404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19248,61,1.69 [1.09-2.61],0.0178600983801199
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,19667,61,1.16 [0.83-1.64],0.3810024578516325
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,22803,71,1.12 [0.44-2.87],0.8084405113968397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,19667,61,2.21 [1.00-4.86],0.0493008727373375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,22626,72,3.02 [1.83-4.99],1.5746119076573252e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,19597,60,1.13 [0.57-2.23],0.719432090577448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,19597,60,2.45 [1.22-4.91],0.0113231879580803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,19591,60,1.42 [0.81-2.49],0.2160439083202439
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,19005,60,0.91 [0.59-1.41],0.6640272372552807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,19591,60,0.91 [0.52-1.60],0.7525784889710804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,22897,73,0.82 [0.48-1.38],0.4484077300795486
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,19597,60,1.13 [0.82-1.56],0.4461221122797462
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,19699,63,1.08 [0.84-1.39],0.5304695496001366
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,22792,70,1.29 [0.81-2.04],0.2858140998616815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,22521,70,0.92 [0.46-1.82],0.8021994389235986
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,22821,68,0.93 [0.64-1.34],0.6946896498614523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,22626,72,1.00 [0.74-1.35],0.999604796575923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,19005,60,0.86 [0.52-1.44],0.5715357492256897
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19005,60,0.60 [0.32-1.15],0.1261357023105436
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19099,60,0.80 [0.49-1.32],0.3800272237791133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19288,62,1.08 [0.85-1.38],0.5207624760850516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,22897,73,1.02 [0.76-1.35],0.917397576910401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,22729,72,0.94 [0.74-1.20],0.6224108396420702
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,22112,69,0.58 [0.27-1.23],0.1551442384191632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,22626,72,3.52 [1.93-6.43],4.081522011095799e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,22897,73,1.36 [0.74-2.48],0.3193197372863295
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,19005,60,0.46 [0.22-0.96],0.039191596063431
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,19288,62,1.27 [0.54-2.99],0.5845086437964582
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,19695,63,1.10 [0.74-1.63],0.631658657617661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,19005,60,1.13 [0.78-1.65],0.5205926544751156
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,19667,61,1.10 [0.89-1.37],0.3616318566525668
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,22729,72,1.06 [0.90-1.25],0.5057999448096373
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22112,69,0.94 [0.61-1.46],0.788244652949048
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,19152,61,0.78 [0.45-1.33],0.3585439520522424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19005,60,1.37 [1.08-1.74],0.009356380836251
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,19099,60,1.16 [0.79-1.70],0.4490698670523533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19152,63,1.83 [1.25-2.69],0.0018949619175201
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,22897,73,1.59 [0.63-4.01],0.3267114077735424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,22630,68,1.02 [0.70-1.47],0.9309198618511638
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,22630,68,2.02 [1.05-3.90],0.036482128832719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,19200,61,1.42 [0.74-2.72],0.2884592237936004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,19288,62,1.06 [0.48-2.31],0.8854995968968284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,19703,63,1.35 [0.53-3.41],0.5289783058774387
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,19152,63,0.99 [0.80-1.21],0.8910124347797985
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,19587,63,0.99 [0.77-1.26],0.9245377874995104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,22060,66,0.90 [0.60-1.34],0.5959069316037692
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,19005,60,0.73 [0.43-1.25],0.2579924427111721
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,19152,61,1.35 [1.06-1.72],0.0136491529687367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22481,70,1.04 [0.79-1.37],0.7561317602694276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,19703,63,1.02 [0.74-1.41],0.8884950021474229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19699,63,1.44 [0.94-2.19],0.0916730585252936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,22873,71,2.23 [1.34-3.71],0.0020807354671438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,22789,72,1.23 [0.76-1.98],0.396517575566693
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19469,62,0.56 [0.26-1.18],0.1277757402501627
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,19099,60,1.06 [0.73-1.55],0.7531168471531537
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,19152,61,1.18 [0.83-1.68],0.354244641083408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,19152,63,0.77 [0.54-1.09],0.1416973689501809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,19667,61,1.06 [0.85-1.31],0.6040456682111139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,19597,60,1.51 [0.97-2.35],0.0649296356671225
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,19005,60,0.83 [0.61-1.14],0.2433898450123839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22470,65,1.45 [0.68-3.11],0.3412169563302606
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19288,62,1.51 [0.83-2.74],0.1732817136461434
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,19703,63,1.35 [0.52-3.53],0.5358244817244482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PI3,Elafin,22326,70,1.09 [0.74-1.61],0.6515862785790523
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19667,61,1.12 [0.82-1.52],0.4790128601028951
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,22340,65,2.75 [1.57-4.83],0.0004182215533636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22585,70,1.35 [0.97-1.87],0.0723028588197444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22630,68,1.97 [0.93-4.17],0.0765608705765519
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19152,63,1.08 [0.72-1.63],0.7169415970009798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,22630,68,1.53 [0.91-2.56],0.1094746151488522
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,22626,72,1.35 [0.92-1.99],0.1237881679726853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19288,62,0.87 [0.62-1.24],0.4424144711180131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,18967,60,1.17 [0.91-1.50],0.2104876348312232
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,19699,63,4.14 [1.67-10.22],0.0020884443761146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,19099,60,1.06 [0.70-1.62],0.7763612569708309
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,22656,72,1.20 [0.89-1.60],0.2251057511075752
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,19320,61,1.15 [0.86-1.54],0.3524857545821662
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,22470,65,1.34 [0.93-1.93],0.1133842374406357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,22695,72,4.19 [2.07-8.47],6.512108895360387e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,22859,73,0.84 [0.52-1.35],0.4670296003861542
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",22553,73,1.06 [0.75-1.50],0.7288171639766448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,22729,72,1.10 [0.87-1.40],0.4301091133828262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,22630,68,1.23 [0.63-2.41],0.5452384163108613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,22828,72,1.32 [0.88-2.00],0.1851019454497954
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,22630,68,1.78 [1.12-2.82],0.0144229844204965
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,22477,71,1.80 [0.84-3.85],0.1322663929478759
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",19658,61,1.07 [0.71-1.63],0.7335057918172418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19152,63,0.63 [0.32-1.24],0.1835949709793011
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19658,61,1.11 [0.86-1.43],0.4163125040739481
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,19658,61,1.17 [0.83-1.65],0.3802767516525331
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,19209,61,0.31 [0.11-0.85],0.0235691439995906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,22060,66,1.18 [0.67-2.10],0.5681832193699197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,22626,72,1.26 [0.79-2.02],0.3375875892893038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,22626,72,1.11 [0.82-1.51],0.4842376262756314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,19627,60,1.30 [0.86-1.95],0.209027347212407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,22809,72,1.57 [0.84-2.91],0.1544630465325807
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,22112,69,0.78 [0.38-1.63],0.5139590817680159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,19658,61,1.90 [0.96-3.77],0.0654823776317953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,22585,70,0.95 [0.73-1.23],0.6861829184864354
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,22795,72,4.51 [2.07-9.83],0.00015580236996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,22560,72,1.12 [0.72-1.74],0.6296867905220348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22520,71,1.02 [0.91-1.15],0.7069643361709326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,19099,60,0.95 [0.70-1.30],0.7629757735293445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,19099,60,1.34 [0.90-2.00],0.1462610151891782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,19152,61,1.05 [0.65-1.68],0.8533184712535742
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,22021,66,1.00 [0.82-1.22],0.9840010214850292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,19703,63,1.02 [0.68-1.51],0.9406855744352708
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,19658,61,1.09 [0.80-1.50],0.5804854359471183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,22620,72,1.05 [0.97-1.14],0.2126119550824905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,19200,61,1.15 [0.75-1.78],0.5247111051517197
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,19090,59,0.73 [0.40-1.36],0.32860680347206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22198,70,1.02 [0.85-1.22],0.8515886061724107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,22521,70,1.55 [0.39-6.23],0.5334914709256323
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,22695,72,1.25 [0.59-2.64],0.5598724339135732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,19152,63,1.79 [1.22-2.62],0.0029747501872262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,19152,63,0.45 [0.18-1.13],0.0896927966410034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22521,70,1.32 [0.80-2.20],0.28138157299739
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,19200,61,0.89 [0.61-1.28],0.5143470086252973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,19703,63,0.54 [0.26-1.11],0.0958425887655027
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,22222,70,2.31 [1.30-4.10],0.0042792659596678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,22729,72,0.69 [0.40-1.19],0.1810704085390413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,19695,63,1.46 [0.79-2.68],0.229488089719101
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,19584,64,0.93 [0.70-1.24],0.6323257625057159
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,22821,68,1.22 [0.78-1.91],0.3815786371940499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,22632,70,1.17 [0.93-1.47],0.1892977347963441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,19320,61,1.50 [1.19-1.87],0.0004472274898604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19695,63,1.05 [0.73-1.53],0.7783395372671374
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,19152,63,1.76 [1.03-3.00],0.0387118183220146
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,22112,69,1.09 [0.57-2.10],0.7930271169243286
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,19152,63,1.01 [0.69-1.49],0.95670363105851
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,19699,63,1.13 [0.71-1.79],0.6137444654284632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,22521,70,1.03 [0.73-1.45],0.8584169076994831
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19591,60,1.10 [0.82-1.48],0.5322812723036034
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22695,72,1.07 [0.87-1.33],0.5265380113027083
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19320,61,1.43 [1.17-1.76],0.0006037862965571
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19667,61,1.17 [0.89-1.54],0.2712023871743745
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19667,61,1.55 [0.93-2.58],0.0938339943383396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,22626,72,1.17 [0.90-1.52],0.2329693024774825
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,22873,71,1.06 [0.85-1.32],0.6112860517501133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19597,60,1.04 [0.84-1.28],0.7239493939764896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,22470,65,1.10 [0.65-1.88],0.7163883075153599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,19152,61,0.83 [0.56-1.23],0.3545849808583727
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,22613,72,0.83 [0.67-1.02],0.0756556928509838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,22112,69,1.26 [0.94-1.69],0.1196681462307724
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,19005,60,0.85 [0.31-2.29],0.7441193911560875
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,19695,63,1.30 [0.72-2.33],0.3842237151970362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,19591,60,0.55 [0.23-1.32],0.1814928686125043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,22764,72,1.73 [0.98-3.02],0.0569391417033183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,22005,64,0.99 [0.76-1.28],0.9098918874968492
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,19363,62,1.10 [0.76-1.59],0.6263950321493137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22198,70,1.15 [0.86-1.53],0.3406016661033058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",22873,71,1.21 [0.87-1.67],0.2495318733667184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,22825,71,1.02 [0.72-1.45],0.895457598943165
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,22198,70,1.09 [0.54-2.18],0.8103388764978647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,22620,72,0.60 [0.27-1.30],0.1933772710375104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,19695,63,1.21 [0.77-1.89],0.4136921720758549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,19695,63,1.16 [0.72-1.88],0.5490453542321543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22198,70,1.27 [0.88-1.82],0.1945388895905227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19152,61,1.08 [0.52-2.26],0.8311152626680178
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22626,72,1.07 [0.83-1.37],0.5933275857915004
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19622,61,1.27 [0.95-1.71],0.1079291524609299
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,22198,70,1.11 [0.70-1.75],0.6503136489710843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,19099,60,0.97 [0.57-1.66],0.9190746778489014
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,19288,62,1.10 [0.90-1.34],0.3413997796285096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22112,69,1.15 [0.84-1.57],0.3795364551563067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,22821,68,0.90 [0.67-1.21],0.4995132840884229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,19658,61,1.78 [1.19-2.65],0.0048468164719548
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,22649,70,0.37 [0.16-0.87],0.0223004146722563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,19099,60,0.59 [0.24-1.42],0.2351665333590712
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,22585,70,0.95 [0.67-1.34],0.764797720483994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,19729,64,0.45 [0.17-1.17],0.1019327989197151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,19150,62,0.95 [0.66-1.36],0.7779354805154964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,19152,63,0.92 [0.54-1.58],0.7671858365303499
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,19200,61,1.98 [1.08-3.62],0.0277888510298385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,22687,71,1.31 [0.90-1.92],0.1643829606272838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,19152,63,1.79 [1.23-2.60],0.0023463235818544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,22558,71,1.58 [0.95-2.62],0.0787041600949057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,19658,61,1.85 [0.99-3.45],0.0537619512688449
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,22544,71,1.89 [1.16-3.05],0.0099051277957898
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22060,66,1.02 [0.84-1.24],0.8583577934519657
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,22825,71,3.51 [1.65-7.44],0.001084886858789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,22036,68,0.77 [0.47-1.25],0.2898865305538772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,19320,61,0.89 [0.37-2.13],0.78868310969676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,19504,62,1.82 [1.00-3.32],0.0497240779600406
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,19597,60,0.89 [0.54-1.45],0.6344990164992039
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,19597,60,1.00 [0.91-1.10],0.9998419782791182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,22470,65,0.89 [0.75-1.06],0.1849591107581632
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,22585,70,1.07 [0.79-1.46],0.6591991146845507
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,22112,69,0.97 [0.60-1.56],0.8956785050482028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,19005,60,0.75 [0.33-1.72],0.4991915813128574
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,19667,61,1.51 [0.98-2.32],0.0598081224322983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,19152,61,1.10 [0.74-1.63],0.628821144644715
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,22521,70,0.96 [0.65-1.40],0.814533792038625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,22440,65,1.18 [0.66-2.09],0.5819914612124444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,22357,64,1.20 [0.66-2.17],0.543840855666543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,22585,70,1.24 [0.84-1.83],0.2885045108442438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,19152,63,1.17 [0.79-1.74],0.4268800140169579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,22585,70,0.98 [0.79-1.21],0.8289691954135685
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,22112,69,1.06 [0.74-1.52],0.7499287807099535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18597,58,1.17 [0.91-1.50],0.2252971644150755
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22060,66,0.78 [0.37-1.61],0.4970487711131358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,22426,69,1.78 [0.94-3.38],0.0780654455012102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,19000,61,1.14 [0.73-1.77],0.5755892840770969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,19699,63,1.22 [0.92-1.62],0.165200877086183
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,19152,61,1.13 [0.83-1.52],0.4428546912987277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22585,70,1.13 [0.69-1.83],0.6320236249212483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,22060,66,1.68 [0.98-2.87],0.0583091610456024
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,22222,70,1.26 [0.83-1.91],0.2834042961926124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,19152,63,1.13 [0.75-1.72],0.5573112835540944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22470,65,0.93 [0.70-1.24],0.6093598879422867
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22690,72,1.03 [0.81-1.31],0.8006380436282827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19114,63,0.78 [0.38-1.60],0.5011139566236267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,19699,63,1.63 [0.73-3.62],0.2321501160946557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,19695,63,2.01 [0.72-5.61],0.182097830169226
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,22897,73,1.23 [0.60-2.52],0.5692983539694725
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,19597,60,1.84 [1.19-2.83],0.0061846364063544
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19597,60,0.94 [0.31-2.88],0.9134574838296352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,22548,70,3.54 [1.53-8.18],0.003115282615901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22390,64,2.73 [1.44-5.17],0.0020263795920265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,19658,61,0.99 [0.50-1.97],0.9747858226505782
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,22897,73,1.18 [0.50-2.77],0.7043617166365512
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19699,63,2.42 [1.19-4.93],0.014400465065729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19288,62,1.20 [0.80-1.80],0.3696951668579132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,21970,66,1.81 [1.34-2.44],9.99237918457528e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,19320,61,0.89 [0.48-1.65],0.705264963915402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,22585,70,1.78 [1.07-2.96],0.0257364842927886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,22713,71,1.21 [0.99-1.48],0.0583577897805456
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,22821,68,1.03 [0.57-1.84],0.9314963768727932
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,19591,60,0.84 [0.50-1.42],0.5168500524661974
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,22060,66,0.89 [0.58-1.38],0.6136018658469773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,19200,61,1.17 [0.69-1.99],0.5656459416769424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,19099,60,1.16 [0.91-1.48],0.2283699341505684
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,19729,64,0.80 [0.54-1.18],0.2634552797540067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,22526,71,1.31 [0.82-2.11],0.2586984989964754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,22666,71,2.92 [1.53-5.57],0.0011112367849948
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,19323,62,1.00 [0.55-1.80],0.997820508399315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,19699,63,1.14 [0.73-1.77],0.5641730104697578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,19699,63,1.14 [0.91-1.43],0.2585949631014799
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,19699,63,1.00 [0.75-1.35],0.988161025534432
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,19591,60,1.05 [0.70-1.57],0.8209242989202256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,19099,60,1.30 [0.91-1.85],0.1432519214859789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,22198,70,1.07 [0.83-1.37],0.6045198156546601
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,19099,60,0.82 [0.57-1.19],0.3002279019084887
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19090,59,0.97 [0.62-1.53],0.910528713613154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,19591,60,0.96 [0.55-1.68],0.8982866754831136
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,22585,70,1.29 [0.86-1.93],0.2203142358889459
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,22060,66,1.01 [0.64-1.57],0.9792183909839396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,19288,62,1.15 [0.84-1.56],0.385257743946345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,22112,69,1.18 [0.84-1.65],0.3335867883744097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,22198,70,1.24 [0.89-1.73],0.2039755470185914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,19152,61,0.89 [0.60-1.32],0.5689657290798273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,22112,69,1.04 [0.66-1.65],0.8529672907412698
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,19320,61,0.57 [0.30-1.06],0.0763874495123389
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,19152,63,0.46 [0.21-1.05],0.0647638824307804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,19591,60,1.09 [0.69-1.73],0.708161160382973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,19200,61,1.20 [0.77-1.87],0.4257986323144386
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,19090,59,0.59 [0.26-1.31],0.1918852440620475
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,22112,69,0.77 [0.46-1.29],0.3242843368602706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,19152,63,1.01 [0.72-1.41],0.9642457494162338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,19320,61,1.16 [0.74-1.81],0.5207272181669191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,22112,69,0.88 [0.45-1.73],0.7183674008877335
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,22730,71,1.08 [0.69-1.70],0.7390204132222713
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,22060,66,0.83 [0.42-1.65],0.6022418459991793
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19005,60,1.25 [0.73-2.13],0.4107231644141105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,22112,69,1.00 [0.70-1.45],0.9810501710805064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,19667,61,1.67 [1.02-2.73],0.0405089339540801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,22080,64,1.52 [1.01-2.30],0.0442460819123269
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,19667,61,1.09 [0.80-1.50],0.5821910535359441
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,19099,60,1.50 [1.07-2.11],0.0192550892650213
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,19005,60,0.94 [0.54-1.62],0.8181126379048461
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,19152,61,0.97 [0.67-1.39],0.8661619682978097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,22521,70,1.25 [0.96-1.64],0.1020075622477666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,22521,70,1.22 [0.86-1.74],0.2659769327150058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,19597,60,1.05 [0.71-1.55],0.8213257530129644
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,19152,63,1.42 [1.14-1.77],0.0015709674441913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,19200,61,1.05 [0.83-1.34],0.6813397955715598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,19591,60,1.13 [0.75-1.72],0.5603828730055433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,22222,70,1.25 [0.87-1.79],0.223386472881042
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19200,61,0.58 [0.17-1.96],0.3775503273143955
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,19667,61,1.02 [0.69-1.52],0.9043033790588636
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,22465,69,1.09 [0.71-1.66],0.6944866987319969
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,22897,73,1.05 [0.73-1.49],0.7980830267115848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,22897,73,1.16 [0.84-1.60],0.3703205856511562
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,19591,60,0.83 [0.44-1.57],0.5705913735850404
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,22662,72,1.26 [0.84-1.90],0.2673025437921196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,19152,63,1.07 [0.69-1.66],0.7638358171957033
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,22630,68,1.62 [0.77-3.42],0.2060125506158923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REN,Renin,22626,72,1.19 [0.92-1.52],0.1795708719831552
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,19152,63,0.98 [0.52-1.83],0.9508766496058906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,19005,60,0.73 [0.34-1.58],0.4309060578143535
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22521,70,1.21 [0.72-2.02],0.4688400574412553
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RETN,Resistin,22558,71,1.26 [0.77-2.07],0.3631691223193189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",19099,60,1.26 [0.85-1.85],0.2447492901374473
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,19591,60,0.92 [0.28-2.99],0.8881645183075298
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,19667,61,1.22 [0.89-1.68],0.2218320590357019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19320,61,1.12 [0.80-1.58],0.5075451265073417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,22821,68,0.78 [0.39-1.57],0.4919679527477554
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,22821,68,0.93 [0.41-2.13],0.8652831510783652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,19667,61,1.15 [0.78-1.71],0.4750488819930858
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,22198,70,0.90 [0.63-1.30],0.5803530852159593
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,22314,65,0.97 [0.80-1.17],0.7490772612537028
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,19152,63,1.38 [0.99-1.92],0.0603414338932393
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19288,62,1.68 [1.11-2.55],0.0146017382123139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,22753,71,1.16 [0.83-1.64],0.3843515008361584
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,19699,63,1.07 [0.84-1.38],0.5854185472041284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19099,60,1.05 [0.75-1.46],0.7959345901576865
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,19667,61,0.94 [0.63-1.40],0.7515123513547256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,19252,62,1.08 [0.87-1.33],0.4857742235843402
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,19703,63,0.65 [0.24-1.78],0.3995239504094996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,19200,61,1.02 [0.62-1.68],0.9254888657869884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,22523,71,1.07 [0.89-1.28],0.4752177966250988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,19037,63,1.54 [0.70-3.42],0.2850660015860407
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,19547,62,1.56 [0.90-2.72],0.1147641958603914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,19667,61,1.24 [0.82-1.87],0.3175191057159438
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,22797,73,1.92 [1.04-3.54],0.0367960846914129
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,19200,61,1.67 [0.84-3.30],0.1440099420277125
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,19152,63,0.43 [0.20-0.91],0.027883186250789
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,19152,63,0.52 [0.23-1.21],0.1297590385854591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,19320,61,1.02 [0.71-1.47],0.9119174232407388
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,22112,69,1.06 [0.77-1.44],0.7280676384059848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,19320,61,1.05 [0.70-1.57],0.8237399155986718
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,19200,61,1.13 [0.80-1.61],0.4851837607994118
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,22662,72,3.05 [1.53-6.08],0.0014872332299318
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,22821,68,2.67 [1.12-6.38],0.0268993456477646
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,19200,61,4.16 [1.09-15.81],0.03662933527832
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22626,72,2.14 [1.11-4.12],0.022535745708497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,22521,70,1.03 [0.62-1.70],0.921163233775762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,19152,63,0.92 [0.41-2.04],0.8291234934583243
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,19320,61,1.16 [0.84-1.60],0.3587867526496319
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,19152,61,0.55 [0.27-1.11],0.0971541297138174
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,19200,61,0.96 [0.52-1.78],0.8914342306345557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,19099,60,0.86 [0.45-1.63],0.6383116737895065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,19152,61,1.08 [0.90-1.30],0.4255233814538856
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,22112,69,1.02 [0.68-1.52],0.9258240958385104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22112,69,1.23 [0.90-1.68],0.1920193452722488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,19090,59,0.94 [0.72-1.23],0.6690461339939255
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,22470,65,0.83 [0.43-1.58],0.5664616249808327
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,22825,71,0.68 [0.32-1.46],0.3186989529270934
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,22521,70,4.08 [2.51-6.64],1.4397752587127584e-08
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,19099,60,0.91 [0.55-1.49],0.704771986017223
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19667,61,1.05 [0.81-1.38],0.7047573676855701
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,22825,71,1.50 [0.90-2.49],0.1228532146809938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,22112,69,1.04 [0.86-1.26],0.6732757653904352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,22821,68,1.03 [0.74-1.44],0.8567246011677595
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,19099,60,1.25 [0.69-2.27],0.4618765524659421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,22445,71,1.24 [0.86-1.80],0.2485406226643843
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,22319,70,0.93 [0.70-1.24],0.6312883992260776
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,19152,63,1.26 [0.67-2.38],0.4777131871955228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,19667,61,1.34 [0.89-2.02],0.162978213607345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,22030,66,0.97 [0.68-1.38],0.8579584718271134
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,19591,60,0.88 [0.48-1.63],0.6884269449226815
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,22695,72,1.03 [0.72-1.49],0.8589671798938188
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,19667,61,1.64 [1.01-2.64],0.0439028342230482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,22222,70,1.31 [0.95-1.81],0.0991287902064777
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,19729,64,0.81 [0.48-1.36],0.4294056762277328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,19667,61,0.86 [0.35-2.11],0.7443946273084416
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,19090,59,0.87 [0.52-1.45],0.5842290980060112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,22585,70,1.07 [0.81-1.44],0.6238139393071688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,19320,61,1.25 [0.97-1.60],0.0856084637097424
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,19624,63,1.11 [0.89-1.39],0.3676706896855579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,19099,60,0.94 [0.47-1.89],0.8615616469389733
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,19099,60,0.82 [0.47-1.42],0.4751030540159591
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,19320,61,1.03 [0.73-1.47],0.8546641421632915
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,19667,61,1.17 [0.56-2.44],0.6748307147286775
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,19657,63,0.72 [0.35-1.47],0.3662412780266786
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,22521,70,1.11 [0.87-1.42],0.4062158287096921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,22821,68,1.12 [0.54-2.34],0.7532879085189873
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,22060,66,1.08 [0.77-1.52],0.6627526907248396
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22048,65,1.80 [0.93-3.49],0.0796915183775437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,22897,73,1.55 [0.96-2.48],0.0705031142182774
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,22821,68,1.57 [0.76-3.27],0.2236693646039078
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,22711,70,1.54 [0.81-2.93],0.1920808255474325
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,22662,72,1.73 [0.93-3.20],0.0826028379237597
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,22656,72,0.83 [0.58-1.19],0.3179567668884285
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,19099,60,0.83 [0.35-1.94],0.6617264380355907
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,19288,62,1.30 [0.49-3.45],0.5924241709533884
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,22690,72,1.02 [0.82-1.27],0.8397894614588314
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,22198,70,1.64 [1.07-2.53],0.0246535975889814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,19090,59,0.87 [0.60-1.26],0.4647468660180909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,22753,71,1.53 [1.02-2.28],0.0391377455811005
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,19090,59,0.45 [0.22-0.90],0.0241197882957426
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,19152,61,0.99 [0.42-2.31],0.9805346247412154
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,19152,61,1.11 [0.61-2.02],0.7350920625750358
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,19090,59,1.15 [0.73-1.83],0.5422817990125259
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,19200,61,1.61 [0.92-2.83],0.0940971988133997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,22112,69,1.25 [0.99-1.57],0.0625615642252896
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,19125,61,1.00 [0.61-1.66],0.9946033317708068
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,19699,63,1.25 [0.52-2.96],0.6180376161301944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,19200,61,1.13 [0.89-1.43],0.3107451334327927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,22585,70,1.13 [0.79-1.62],0.5109906538396869
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SCT,Secretin,19152,61,0.85 [0.50-1.46],0.5572530806989355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,22626,72,2.05 [1.38-3.04],0.0003629604001926
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,22626,72,0.72 [0.46-1.13],0.1541084028232568
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,19591,60,1.08 [0.87-1.34],0.5011866309830764
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,19597,60,1.44 [1.10-1.89],0.0080999988928357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,19288,62,1.13 [0.60-2.11],0.7096557427060097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,19200,61,1.11 [0.80-1.55],0.5177674441377964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,19200,61,1.26 [0.67-2.36],0.478072428282142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,22897,73,1.34 [0.89-2.03],0.1600269076753788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,19729,64,0.41 [0.14-1.21],0.1069171131891067
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,19729,64,0.47 [0.17-1.27],0.1367478250191889
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,22687,71,1.26 [0.88-1.80],0.21300282835376
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,22585,70,1.60 [0.71-3.61],0.2539881326821953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,22626,72,1.51 [0.68-3.35],0.3097803974319126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,19288,62,1.25 [0.72-2.17],0.4346246818965941
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,22521,70,1.36 [0.72-2.57],0.3454662087743625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,22821,68,0.95 [0.46-1.96],0.8898562081642912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,19152,63,1.02 [0.41-2.51],0.9697338725515576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,22828,72,3.24 [2.02-5.20],1.0338262998038346e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,19667,61,0.95 [0.67-1.33],0.7526712585477631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,19320,61,1.03 [0.66-1.61],0.8914970688202878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,19617,61,1.65 [0.85-3.18],0.1373446026143811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,22521,70,1.22 [0.61-2.45],0.5670911289551108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,19340,62,0.44 [0.07-2.94],0.3944658597094953
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,22897,73,1.61 [0.96-2.71],0.0726205359223455
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,21979,68,1.10 [0.92-1.31],0.2965348681040524
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,19649,64,0.61 [0.22-1.69],0.3447989120781909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,19350,62,0.76 [0.28-2.10],0.5986596649167977
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19424,63,0.71 [0.32-1.56],0.3933950697737352
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,19729,64,0.57 [0.13-2.47],0.4560601091855345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,19729,64,2.22 [0.65-7.55],0.2009702828611938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,22390,70,1.45 [1.10-1.92],0.0077365317113619
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,22559,68,1.00 [0.79-1.27],0.9769710331399186
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,22222,70,0.91 [0.60-1.38],0.6477420476932465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,22749,67,1.03 [0.71-1.48],0.888953469256599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,22873,71,1.06 [0.76-1.48],0.738611806791853
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,22470,65,1.00 [0.52-1.93],0.9884427460886096
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,19685,64,0.46 [0.17-1.23],0.1222662958778578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,19685,64,0.39 [0.17-0.93],0.0328024959405984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,22897,73,1.02 [0.75-1.38],0.9206888189063516
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,19699,63,0.94 [0.65-1.37],0.7478798915122058
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,19426,63,0.71 [0.28-1.80],0.4723737857681886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,19347,60,0.49 [0.16-1.45],0.196180727417471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,19685,64,0.74 [0.35-1.60],0.4456100590165908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,19320,61,1.09 [0.90-1.32],0.3885420764575003
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,19245,62,1.31 [0.64-2.71],0.4630894676265097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,19597,60,1.12 [0.73-1.71],0.6191718737593401
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22060,66,1.31 [0.97-1.78],0.0798447792425184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,22408,65,1.48 [0.75-2.94],0.2626552426618289
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,19152,61,1.96 [1.04-3.67],0.0365543265894836
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,22695,72,2.18 [1.05-4.53],0.036463875505966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,22521,70,3.03 [1.46-6.29],0.0029789282801989
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,22521,70,1.05 [0.79-1.38],0.7584566901997353
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,22404,65,0.98 [0.58-1.64],0.9332771151599444
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,19288,62,0.97 [0.53-1.76],0.9166243026397805
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,22112,69,1.01 [0.70-1.46],0.9578459724832998
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,22112,69,0.70 [0.44-1.10],0.1256981999021557
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,22626,72,1.34 [0.98-1.83],0.0653255429955765
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,19346,62,1.19 [0.79-1.79],0.4035319055439643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,22112,69,1.10 [0.88-1.38],0.393725115582261
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,22585,70,0.89 [0.60-1.33],0.5756441637291513
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19090,59,1.01 [0.66-1.52],0.97929579861313
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,19597,60,0.97 [0.58-1.61],0.89821987089047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,19215,61,1.30 [0.98-1.71],0.0670882182974377
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,19658,61,1.03 [0.72-1.48],0.86128446465585
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,19703,63,1.20 [0.77-1.88],0.4205422473304182
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,19005,60,1.16 [0.96-1.40],0.1363119845329168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,19058,58,1.00 [0.76-1.33],0.9815504857421588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,19152,63,0.82 [0.46-1.47],0.5070385374116646
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,19695,63,1.80 [0.86-3.77],0.1168859785991983
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",22690,72,1.17 [0.92-1.49],0.1991186515760221
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,19320,61,0.76 [0.38-1.49],0.4172913297534187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,22659,72,1.31 [0.85-2.03],0.2228757792668413
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,22729,72,1.78 [1.13-2.81],0.0134975798642545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,22585,70,2.56 [1.41-4.66],0.0020060703320364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,22060,66,1.08 [0.84-1.39],0.5319095097637592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,22630,68,1.15 [0.93-1.43],0.1942829517902688
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,22825,71,1.25 [0.66-2.36],0.4957514854832036
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,22626,72,2.33 [1.15-4.72],0.018895588572787
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,19200,61,1.56 [0.90-2.68],0.1110384790125344
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,22792,71,0.90 [0.44-1.85],0.7793345744350648
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,19200,61,1.39 [0.78-2.46],0.2604717857834639
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22676,71,1.05 [0.72-1.52],0.812290412331418
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,22586,72,1.45 [0.92-2.28],0.1090969707360792
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,19152,63,0.69 [0.44-1.07],0.1002618315765355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,22521,70,1.05 [0.82-1.33],0.7158956834881912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22060,66,1.08 [0.75-1.55],0.6875586033817762
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22198,70,1.28 [0.89-1.85],0.1885598590995302
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,22421,64,1.07 [0.80-1.44],0.6282097945286247
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,22729,72,1.00 [0.82-1.22],0.9945893825346794
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,19099,60,1.24 [0.73-2.09],0.4220454590723209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,19667,61,1.05 [0.83-1.33],0.7041555769090273
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,22198,70,1.40 [0.96-2.03],0.0772065284920228
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,22112,69,1.27 [0.72-2.23],0.4090012703085321
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,22585,70,0.97 [0.67-1.41],0.8744362733178723
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,22112,69,1.77 [1.19-2.63],0.0048875466998084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,19099,60,0.94 [0.37-2.35],0.886837405118555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,19591,60,0.85 [0.52-1.39],0.5282589466521382
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,22060,66,0.97 [0.66-1.42],0.8639921469453367
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,19152,61,1.05 [0.67-1.66],0.8323898218781551
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,22060,66,1.12 [0.83-1.53],0.4545608514232054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,19005,60,0.75 [0.45-1.24],0.2631067884668506
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,19005,60,1.01 [0.61-1.66],0.9810371620800604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,22060,66,1.16 [0.63-2.14],0.6376436622117483
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,22585,70,1.33 [1.00-1.76],0.0477671677720676
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,19152,61,1.15 [0.86-1.53],0.3502640505427185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,19695,63,1.47 [0.91-2.39],0.1180300506449329
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,19099,60,0.96 [0.69-1.32],0.7880524201140833
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19288,62,1.15 [0.86-1.53],0.3513227705250338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19597,60,1.07 [0.68-1.67],0.7821274912363675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19005,60,0.84 [0.52-1.37],0.4863881120484545
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,22060,66,1.28 [0.89-1.85],0.1820586266953238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,19152,63,0.81 [0.37-1.74],0.5819112747434514
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,22825,71,1.26 [0.73-2.20],0.4070753414570383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,22222,70,1.21 [0.66-2.21],0.5408448967446372
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,19320,61,1.24 [1.00-1.55],0.0525830658931905
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,19597,60,1.00 [0.74-1.35],0.9962179429346442
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,19541,63,0.98 [0.52-1.84],0.9383842219989108
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,22112,69,1.12 [0.87-1.46],0.3750956681164293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,19591,60,1.12 [0.79-1.58],0.5332029060788626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,19591,60,1.40 [0.88-2.21],0.1548819556392729
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,22521,70,0.59 [0.21-1.64],0.3134692286454922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,22060,66,0.91 [0.66-1.25],0.5645642374836064
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,19005,60,1.39 [1.01-1.92],0.0430301057637569
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,19597,60,0.99 [0.67-1.48],0.9773980573857284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,22825,71,1.58 [0.84-2.98],0.1535319760822689
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,22729,72,1.27 [0.74-2.19],0.3843618263044783
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,22705,65,1.34 [0.86-2.10],0.194036680626084
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,19152,63,0.73 [0.41-1.29],0.2745330010127227
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22695,72,1.02 [0.73-1.41],0.9183010928051392
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19591,60,1.04 [0.77-1.40],0.8118440925886643
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,19090,59,1.12 [0.79-1.59],0.5339234655999023
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,19626,61,1.12 [0.88-1.43],0.3564144905250931
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,22626,72,1.05 [0.82-1.34],0.7059096266428357
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,19090,59,1.04 [0.61-1.77],0.8907655538640362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,22695,72,1.04 [0.83-1.31],0.7217489846683349
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,19667,61,1.23 [0.82-1.86],0.3196459643360599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,19288,62,1.08 [0.87-1.33],0.5024950943778025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,22470,65,1.22 [0.88-1.70],0.2300444560537849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19200,61,1.63 [0.92-2.88],0.0956797355705922
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',19658,61,0.92 [0.51-1.65],0.7777117938304132
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,19099,60,0.99 [0.67-1.47],0.9708463525858302
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,19288,62,1.48 [0.97-2.26],0.0681896594249411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,19597,60,0.89 [0.50-1.61],0.7114288202018151
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,19591,60,1.17 [0.89-1.54],0.2711080221595588
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,19200,61,1.34 [0.63-2.87],0.4440082022295498
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,22626,72,1.34 [1.00-1.80],0.0465306323486137
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],22141,68,1.04 [0.67-1.61],0.8543929755141938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",22630,68,1.24 [0.73-2.12],0.4249726212314102
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,19703,63,1.05 [0.71-1.55],0.8129870011187171
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,19667,61,1.12 [0.65-1.95],0.6742286456933857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,22112,69,1.29 [0.71-2.34],0.4029593378819421
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,22716,71,1.08 [0.79-1.47],0.6356336398209085
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,22591,71,1.52 [0.87-2.66],0.14476616647699
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,22591,71,0.84 [0.49-1.45],0.5340221550633022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19152,61,0.76 [0.42-1.38],0.3698477395255072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,19640,61,1.85 [0.72-4.73],0.2001325948257308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,19152,61,0.59 [0.24-1.47],0.2586248192382748
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19667,61,1.14 [0.52-2.51],0.749887697796098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,19667,61,1.28 [0.91-1.80],0.1605364339147489
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,22695,72,0.92 [0.69-1.23],0.5880301084094355
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,22614,71,0.82 [0.38-1.77],0.6138938374464864
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPART,Spartin,19288,62,1.29 [0.95-1.75],0.1050329574588153
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,19699,63,1.57 [0.71-3.48],0.2701437593835609
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,22630,68,1.43 [0.93-2.22],0.1055471687369812
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,19288,62,1.03 [0.55-1.96],0.9195323792344166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,22585,70,1.24 [0.91-1.67],0.1680059802720968
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,22630,68,1.97 [1.04-3.72],0.0369229727992431
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,22825,71,1.43 [0.96-2.14],0.0767731523248094
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,19099,60,0.64 [0.28-1.43],0.2757158023883458
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,22566,68,3.64 [2.11-6.25],3.051758863981109e-06
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,22729,72,1.10 [0.66-1.82],0.711335590710453
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,19597,60,1.10 [0.90-1.36],0.3421200837617419
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,22470,65,0.96 [0.40-2.28],0.9197872198747944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,22662,72,2.05 [1.15-3.66],0.0154539388678279
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,22525,71,2.58 [1.47-4.52],0.000900214800631
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,22858,73,1.93 [1.25-2.97],0.0027874356761962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19152,63,1.06 [0.61-1.83],0.8447387756200868
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,19005,60,0.77 [0.46-1.29],0.3252932738707211
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,19320,61,1.08 [0.83-1.42],0.5511080344779133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,19658,61,1.04 [0.75-1.46],0.7958587289200189
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,22198,70,1.05 [0.84-1.32],0.6662233264147992
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19090,59,1.00 [0.47-2.12],0.9938781578818384
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,19658,61,1.08 [0.58-2.01],0.8092187966522361
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,22655,72,1.07 [0.90-1.28],0.425672751482433
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,22521,70,1.16 [0.83-1.62],0.3845933981423921
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,22585,70,1.13 [0.89-1.43],0.3309188061970343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,19699,63,3.29 [1.65-6.56],0.0007215836076308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,22060,66,1.20 [0.88-1.63],0.2402734927102272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19152,63,0.94 [0.47-1.90],0.8648804970009398
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22591,71,0.84 [0.69-1.03],0.0998573603332235
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22687,71,1.17 [0.71-1.94],0.5399295627673217
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,19005,60,1.07 [0.47-2.46],0.8718747697066265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,19597,60,1.29 [0.83-2.00],0.2667617486695913
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,19288,62,1.16 [0.76-1.77],0.4976354294006497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22521,70,1.02 [0.61-1.70],0.9437310691978592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22897,73,1.44 [0.71-2.90],0.3119084331655138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19152,63,0.84 [0.46-1.51],0.5583042728546322
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,19695,63,1.76 [0.78-4.01],0.1752710333463219
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,19591,60,1.08 [0.57-2.02],0.8148956282090009
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,22421,64,1.15 [0.82-1.62],0.4222945991208681
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,19152,63,1.09 [0.79-1.50],0.5904832541622127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,22521,70,1.13 [0.97-1.32],0.1264158092557944
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19005,60,0.87 [0.58-1.31],0.5106178441565798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,22821,68,1.12 [0.67-1.87],0.6606189909751893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,22597,68,0.71 [0.32-1.57],0.396223270532863
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,19090,59,1.01 [0.73-1.40],0.9297303976491658
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,22600,68,1.12 [0.82-1.55],0.4746429478737596
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,22222,70,1.17 [0.88-1.56],0.2862463146388808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,22060,66,1.01 [0.71-1.44],0.9692026121162662
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,22626,72,1.15 [0.90-1.46],0.267372251121088
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",19005,60,0.99 [0.76-1.30],0.9509451605898938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,22112,69,1.28 [0.94-1.73],0.1190139173489073
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,19152,61,0.95 [0.51-1.78],0.8822524239657854
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,19658,61,1.04 [0.57-1.90],0.889527768516906
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,22521,70,1.04 [0.73-1.47],0.8288409887354738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,19152,63,1.09 [0.64-1.87],0.7477419301857827
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,22112,69,0.76 [0.52-1.10],0.1497997201655317
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,19152,63,0.79 [0.48-1.29],0.3377506913356196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,22585,70,0.97 [0.62-1.50],0.874412096786661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,19667,61,1.22 [0.89-1.69],0.2193965906629541
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,22112,69,0.86 [0.51-1.45],0.5711431068853345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,19597,60,0.96 [0.52-1.77],0.8879977116361626
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,22112,69,1.18 [0.90-1.54],0.2368071524389803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,22821,68,1.01 [0.86-1.20],0.8901688362582162
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,22585,70,1.70 [1.34-2.16],1.2797042604860954e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,19152,63,1.03 [0.74-1.43],0.8558571781277565
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22821,68,1.26 [0.82-1.92],0.2870055610738198
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",19667,61,1.60 [1.18-2.18],0.0024520497097901
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,22222,70,0.72 [0.47-1.11],0.1360638239324675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,22630,68,1.53 [0.79-2.97],0.2075806412348214
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,19591,60,1.53 [1.00-2.35],0.0523591220127054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19172,62,2.11 [1.03-4.32],0.0403656180319549
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,19152,61,1.48 [1.13-1.95],0.0045857628191844
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,19597,60,1.07 [0.55-2.09],0.8405548324559448
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,19288,62,1.49 [1.00-2.22],0.0479926884304667
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19090,59,0.73 [0.43-1.23],0.2403872270074127
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,19658,61,0.75 [0.36-1.57],0.4472299335244082
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,19699,63,0.98 [0.70-1.36],0.9076764599212168
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19320,61,1.12 [0.89-1.42],0.3269638719030996
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,22521,70,1.10 [0.92-1.33],0.2936864426551878
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,20094,64,2.69 [1.71-4.23],1.8047156290182885e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,19591,60,0.82 [0.43-1.57],0.553511516212687
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,22521,70,1.50 [0.85-2.67],0.1651158390456659
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,19005,60,0.72 [0.47-1.13],0.1509363110527919
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,19612,63,1.20 [0.71-2.01],0.499802257755103
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,22198,70,1.06 [0.78-1.45],0.6879560454758773
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,19320,61,1.01 [0.68-1.51],0.9499694517814604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,22060,66,1.10 [0.84-1.45],0.4867445518823672
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19152,61,0.89 [0.62-1.26],0.5018363883973728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19591,60,0.96 [0.49-1.88],0.9115960904582338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,19658,61,1.21 [0.85-1.74],0.2884845401976474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,22060,66,1.36 [0.93-2.00],0.1175637879173302
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,22521,70,1.10 [0.87-1.39],0.4200308364130021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,22585,70,1.03 [0.79-1.34],0.8187576913146728
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,19288,62,1.18 [0.89-1.56],0.2405996055722842
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,22470,65,1.02 [0.82-1.28],0.8365663452966894
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,22470,65,1.07 [0.81-1.40],0.6300425732662982
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,22112,69,1.11 [0.86-1.43],0.4355039732055678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,19152,61,0.98 [0.58-1.64],0.9378183713898904
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,22431,65,0.89 [0.70-1.12],0.3157020351147988
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,22222,70,0.88 [0.65-1.20],0.4203568535691471
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,19292,62,1.39 [0.71-2.70],0.335799698529142
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,22858,73,1.13 [0.58-2.19],0.7279834459945242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,19699,63,1.02 [0.47-2.22],0.9593132724720312
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,19320,61,1.23 [0.89-1.68],0.2089195025016666
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,19699,63,3.34 [1.48-7.55],0.0037282020299284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,22060,66,0.90 [0.77-1.06],0.2067403767482443
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",19152,61,0.71 [0.34-1.51],0.37874444592527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,19591,60,0.93 [0.64-1.34],0.701927870190697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,22060,66,0.98 [0.76-1.28],0.8992913851741046
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,19099,60,0.91 [0.50-1.67],0.7643458894517772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,22695,72,2.29 [0.89-5.85],0.0846003569834871
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,19152,63,0.80 [0.34-1.87],0.6058542244270233
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,19284,61,0.99 [0.77-1.27],0.9305424817987112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,19152,61,1.00 [0.53-1.88],0.9990414081010164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,19320,61,0.50 [0.22-1.15],0.1042007731839849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,19729,64,0.66 [0.22-1.96],0.4513478001111984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,19090,59,0.71 [0.43-1.15],0.1657038036955307
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,22519,67,1.27 [0.99-1.62],0.0601440735276838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,22690,72,1.54 [1.10-2.15],0.010938705342895
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,22583,71,1.52 [1.11-2.09],0.0088598825089192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,22540,69,1.30 [0.67-2.51],0.4389906985352065
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,22622,71,1.20 [0.72-2.00],0.4820343283027594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,22698,70,0.98 [0.56-1.71],0.948080456244464
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,19591,60,0.92 [0.74-1.14],0.4404232472594738
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,22585,70,1.27 [0.83-1.94],0.2662369089193385
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,22833,71,1.89 [1.15-3.11],0.0118817425620656
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,19591,60,1.07 [0.69-1.67],0.7677904815415002
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,22463,69,3.18 [1.59-6.36],0.0011179504607624
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,19152,63,0.42 [0.13-1.42],0.1644258383946107
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,22695,72,1.73 [0.96-3.11],0.0681665625218966
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,22897,73,0.94 [0.51-1.74],0.8407864206276543
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,22596,72,1.09 [0.83-1.43],0.5290332773962663
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,19703,63,1.45 [0.59-3.62],0.4199198356035839
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,18967,60,0.93 [0.69-1.25],0.6465603478199059
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,22626,72,1.58 [0.76-3.30],0.2210357418893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,22630,68,2.78 [1.90-4.08],1.6310499614153816e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,22609,70,1.41 [0.89-2.25],0.1471520813845509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,22522,71,1.18 [0.60-2.32],0.6277457864094647
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,22222,70,0.55 [0.31-0.97],0.0387181182083131
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,19099,60,1.10 [0.92-1.32],0.3031549782896395
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,19006,61,1.60 [0.87-2.94],0.1286677107997445
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,19564,60,1.08 [0.82-1.43],0.5858978821539054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,22821,68,1.45 [0.69-3.05],0.3322444567372408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,21977,66,1.04 [0.86-1.24],0.6964878418235234
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,22897,73,1.14 [0.67-1.91],0.633983831617098
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22011,65,0.92 [0.57-1.49],0.7461092295007801
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19320,61,1.17 [0.62-2.21],0.6188998719416297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22687,71,1.57 [0.99-2.49],0.0552439367678661
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19699,63,1.10 [0.61-1.98],0.7564403129570192
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19658,61,1.20 [0.91-1.59],0.1988601759801104
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,22351,70,3.19 [2.04-4.99],3.700011230390211e-07
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,19699,63,0.59 [0.19-1.86],0.370913898138556
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,22729,72,0.98 [0.84-1.14],0.8022177058276081
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,22630,68,1.28 [0.78-2.12],0.3332189662240284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,22550,71,2.25 [0.90-5.64],0.0844587856329238
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,22695,72,1.15 [0.89-1.47],0.2858895447763928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,19090,59,0.66 [0.33-1.32],0.2447292914736463
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",19320,61,1.08 [0.64-1.82],0.7810312322743351
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,19152,63,1.41 [0.60-3.32],0.4299973746537576
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,19320,61,3.50 [1.33-9.21],0.0112731089411013
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,22873,71,0.91 [0.65-1.26],0.5600226737810277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,19152,63,0.49 [0.20-1.19],0.1134459884507403
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19152,61,1.00 [0.64-1.57],0.9990432528328592
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,19320,61,0.82 [0.50-1.35],0.4326022251964768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,19099,60,0.70 [0.35-1.43],0.3322905942854927
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,19099,60,0.96 [0.61-1.50],0.8415716356856293
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,19597,60,1.11 [0.87-1.41],0.4084959381011599
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,19591,60,0.94 [0.66-1.34],0.7301928232215054
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,19200,61,1.39 [0.98-1.96],0.061262389181184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,19667,61,1.46 [0.99-2.15],0.0572277364540256
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,19005,60,0.89 [0.48-1.66],0.7197808539058326
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,19090,59,1.10 [0.82-1.47],0.5163293142817305
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,19617,61,1.32 [0.73-2.39],0.366246975927567
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,22521,70,1.12 [0.89-1.40],0.3514594905186637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22362,65,1.12 [0.63-2.02],0.6928934002467704
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,22630,68,1.06 [0.79-1.41],0.7120148515347277
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,22687,71,1.23 [0.80-1.88],0.3486509793633022
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,22181,70,1.16 [0.73-1.86],0.5269815248250583
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19597,60,1.15 [0.71-1.86],0.5645087249996383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22198,70,0.94 [0.52-1.68],0.8232287899806678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19288,62,1.29 [0.90-1.86],0.1652849231969474
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22470,65,1.69 [0.97-2.92],0.0615560609245938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22470,65,1.38 [1.06-1.80],0.0182836013309369
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22659,72,1.32 [0.85-2.03],0.2142357840792348
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22873,71,1.52 [0.90-2.55],0.1161108657446984
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22620,72,2.87 [1.53-5.38],0.0010346273731019
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22695,72,1.64 [0.93-2.90],0.0887840700204877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22662,72,1.35 [0.70-2.61],0.3679711673409768
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22198,70,0.80 [0.47-1.36],0.4143443801335482
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22662,72,1.93 [1.00-3.70],0.0485892404379209
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19288,62,0.89 [0.48-1.63],0.7024416664576798
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22825,71,1.19 [0.61-2.32],0.6150556717177218
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22630,68,1.97 [1.00-3.87],0.0493284119795265
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22630,68,1.37 [0.88-2.15],0.1678860615829613
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22821,68,2.30 [1.08-4.86],0.0299606261750292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22833,71,1.91 [1.17-3.14],0.0102974477258047
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22470,65,1.86 [1.40-2.45],1.3536294335753032e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22821,68,0.82 [0.50-1.35],0.4408157896836937
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22470,65,1.11 [0.64-1.94],0.7019855838549397
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,22873,71,0.80 [0.36-1.81],0.5973598261915272
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,22585,70,0.69 [0.49-0.98],0.0391281972782343
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,22873,71,0.93 [0.45-1.92],0.8528538246214914
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,22729,72,1.95 [0.90-4.23],0.089465415674074
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22858,73,2.02 [1.17-3.50],0.0116311938285857
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,22470,65,1.07 [0.73-1.57],0.7129113358864579
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,19695,63,1.92 [1.05-3.53],0.0347995255485678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,19658,61,1.16 [0.89-1.52],0.2766165084662909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,19695,63,0.80 [0.46-1.38],0.4212683914972707
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",22222,70,0.79 [0.65-0.96],0.0153262000007679
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,19320,61,0.79 [0.38-1.64],0.5324512568640091
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,22470,65,1.45 [0.86-2.42],0.1608634266212928
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,22630,68,1.00 [0.43-2.32],0.9992777426843338
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19699,63,1.08 [0.80-1.47],0.6102094837539803
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,19597,60,0.93 [0.73-1.17],0.5233673939563229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",19005,60,0.83 [0.48-1.46],0.5231980764712139
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,19152,63,1.18 [0.88-1.58],0.273796042351092
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,19200,61,0.86 [0.52-1.41],0.5446172169058191
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,22112,69,1.16 [0.70-1.91],0.5635853913622912
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,19152,63,1.07 [0.82-1.40],0.6220599651086283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,18865,61,1.45 [0.93-2.25],0.0971877069243297
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,22222,70,0.68 [0.30-1.52],0.3443062764263417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,19152,61,1.30 [0.64-2.61],0.4670069491046308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,19152,61,1.08 [0.62-1.88],0.7757266318437877
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,19288,62,1.11 [0.88-1.40],0.3729630616003284
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,19699,63,0.86 [0.35-2.09],0.7324342010993994
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,19099,60,1.14 [0.66-1.95],0.6389806890667308
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,22112,69,1.15 [0.87-1.51],0.3316729876551902
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,22477,72,1.35 [0.89-2.04],0.1615091614967849
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,19320,61,1.03 [0.77-1.38],0.8440907905004496
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,22060,66,1.44 [1.00-2.08],0.0487897329006987
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,19099,60,1.30 [0.92-1.84],0.1296169202943886
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,19005,60,0.72 [0.44-1.18],0.1908488283769215
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,22835,70,1.36 [0.91-2.04],0.1389365690946909
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,19667,61,1.04 [0.56-1.94],0.8945182234214206
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,19152,63,1.04 [0.43-2.52],0.9320249028989128
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,22198,70,0.95 [0.67-1.34],0.7674880132735276
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,22585,70,1.21 [0.90-1.61],0.2069132588210185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",19152,63,0.39 [0.17-0.89],0.0246009609837848
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19099,60,0.99 [0.59-1.66],0.9598322040452508
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19320,61,1.07 [0.82-1.40],0.6228663214150754
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,19695,63,1.19 [0.86-1.66],0.2977044074056634
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,22620,72,0.99 [0.66-1.48],0.9703709190951229
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,19703,63,0.94 [0.59-1.49],0.7940695503279116
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,22630,68,0.90 [0.46-1.76],0.7629226551642706
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,22825,71,1.07 [0.77-1.49],0.6907648667541747
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,22585,70,1.05 [0.80-1.38],0.7088312880700016
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,19277,61,1.40 [1.04-1.89],0.0277424049559697
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19597,60,1.01 [0.80-1.27],0.929657194022674
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,19005,60,1.18 [0.83-1.68],0.3467684483067124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,19152,61,0.91 [0.64-1.29],0.5796519261060494
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,22585,70,1.10 [0.86-1.41],0.4351435239771466
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,19591,60,1.13 [0.85-1.49],0.4102678708160437
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,19099,60,0.42 [0.22-0.81],0.0094134166446504
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,19152,63,0.82 [0.55-1.24],0.349852031108682
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,19667,61,1.11 [0.79-1.56],0.5499916284965283
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,22626,72,0.91 [0.71-1.16],0.4341971442817038
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,22222,70,0.95 [0.66-1.35],0.7602530045149138
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,19099,60,1.61 [0.91-2.87],0.1037735060670148
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,22222,70,1.00 [0.46-2.16],0.9947513543832518
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,19099,60,1.03 [0.64-1.64],0.9132549655558364
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,19090,59,1.04 [0.81-1.35],0.7546754830729612
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,19597,60,1.20 [0.95-1.51],0.1220670859693866
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,19152,63,1.20 [0.69-2.11],0.5153952365730216
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,22022,66,0.96 [0.71-1.29],0.780550047621072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,19152,61,1.19 [0.74-1.93],0.4754848855679345
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTN,Titin,19099,60,1.15 [0.84-1.59],0.3826334742259903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,19503,63,0.61 [0.34-1.08],0.0918585857483025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,19090,59,0.75 [0.30-1.88],0.5386532501213029
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,19695,63,1.10 [0.82-1.46],0.5337463102776362
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,19320,61,1.10 [0.82-1.46],0.5327655015311903
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,22470,65,1.09 [0.85-1.40],0.4876808046075315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,19361,62,0.98 [0.57-1.68],0.9427433779294409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,22695,72,2.05 [1.02-4.13],0.044587469431821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,22821,68,1.08 [0.79-1.48],0.6205273297978062
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,19658,61,1.04 [0.66-1.65],0.8507109907032838
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,19054,59,1.01 [0.79-1.30],0.939779349200465
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22630,68,1.21 [0.77-1.90],0.4124010694432105
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,22480,72,1.27 [0.92-1.73],0.1412058423247409
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,22626,72,1.82 [0.87-3.81],0.1144675977229199
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19152,63,1.37 [0.92-2.04],0.1268626454864213
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,22521,70,1.22 [0.68-2.19],0.5135680667820013
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,19591,60,0.99 [0.43-2.28],0.9871026795321196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19699,63,1.32 [0.90-1.93],0.154363367959652
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19152,63,0.76 [0.47-1.23],0.2641763471498923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,19099,60,0.46 [0.22-1.00],0.0494800160010173
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,19288,62,1.34 [0.96-1.87],0.0874293504335497
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19597,60,1.08 [0.90-1.29],0.3986865175219678
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,19099,60,1.01 [0.79-1.30],0.9147773958296808
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,19099,60,1.10 [0.58-2.05],0.7765028218856231
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,22470,65,2.45 [1.48-4.05],0.0004955959369964
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,22833,73,0.72 [0.50-1.02],0.0630815120563015
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,19152,63,0.60 [0.23-1.59],0.3082626813919292
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,19005,60,1.16 [0.77-1.72],0.4801927897767488
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,19591,60,0.55 [0.25-1.21],0.1391251410684587
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,19699,63,1.45 [1.16-1.82],0.0011100866280604
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,19090,59,1.00 [0.60-1.65],0.9923505591368412
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,19292,61,1.11 [0.76-1.63],0.5775701200879589
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,19288,62,1.22 [0.87-1.72],0.2553941896958479
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,19152,61,0.95 [0.66-1.37],0.7701828710469938
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,22521,70,1.12 [0.89-1.42],0.3356355071707578
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,19591,60,1.21 [0.86-1.70],0.2704757219754675
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,19658,61,1.13 [0.62-2.05],0.6820241567611408
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,19099,60,1.14 [0.87-1.48],0.3398714509917625
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,22222,70,1.16 [0.93-1.43],0.1861913656868044
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,22112,69,1.56 [1.19-2.05],0.0014074864901301
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,22222,70,1.60 [1.27-2.01],5.152706848075891e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,19152,63,1.27 [0.97-1.66],0.0798592220847111
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,22585,70,0.93 [0.71-1.20],0.563145930609527
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,22238,69,1.34 [0.62-2.93],0.4592732637490248
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,19703,63,1.22 [0.88-1.69],0.2228572909670819
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22521,70,0.31 [0.10-0.93],0.0368881069231511
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,19090,59,1.09 [0.85-1.40],0.5081941383275732
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,22649,70,3.92 [2.11-7.29],1.5647384470681858e-05
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,22821,68,0.90 [0.44-1.83],0.7673154134203751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,19005,60,1.10 [0.85-1.42],0.4706437637796804
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,22803,70,0.94 [0.65-1.35],0.7462310035370997
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,19152,63,1.12 [0.48-2.63],0.7947708108358267
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,22695,72,0.90 [0.63-1.30],0.5870583708395057
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,22833,71,1.13 [0.61-2.10],0.690529397073598
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,19667,61,1.39 [0.63-3.08],0.4121040613050281
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,22222,70,0.96 [0.80-1.14],0.6156192791655637
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,19200,61,0.50 [0.17-1.50],0.2173626744756185
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,19699,63,0.95 [0.49-1.83],0.8745609567364135
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,22521,70,0.97 [0.72-1.32],0.8633159470997417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,19703,63,1.09 [0.78-1.53],0.602245872234716
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,22521,70,1.16 [0.71-1.88],0.5509408174985133
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,19320,61,1.20 [0.85-1.69],0.2963032422303043
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,22521,70,1.18 [0.91-1.53],0.2017874336041322
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,19591,60,1.09 [0.84-1.42],0.5027276985921649
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,22521,70,1.20 [0.92-1.57],0.1731579856494814
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,19591,60,1.28 [0.70-2.34],0.424022824671641
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19099,60,1.22 [0.61-2.43],0.5804443662151936
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,19591,60,1.40 [0.98-2.01],0.0640977922431356
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,22597,68,1.21 [0.71-2.08],0.4876494488197751
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22591,72,1.20 [0.87-1.64],0.271860707075788
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,19658,61,1.19 [0.64-2.20],0.580490485342962
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,22060,66,1.20 [0.78-1.84],0.4098744951948411
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,19320,61,1.35 [0.88-2.06],0.1687171853768166
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22222,70,1.18 [0.86-1.61],0.3028200798577196
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22821,68,1.09 [0.81-1.46],0.5759553547254536
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,22112,69,1.23 [0.63-2.42],0.540948300633112
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19288,62,1.19 [0.80-1.76],0.396674235938072
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,22786,71,1.51 [0.93-2.47],0.0982180541411315
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,19005,60,1.20 [0.96-1.51],0.1046955091038908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22386,64,1.60 [0.90-2.84],0.1084751028461457
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,19667,61,1.22 [0.81-1.85],0.3467507691950025
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,22897,73,1.18 [0.89-1.57],0.2453263715331124
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",22630,68,1.44 [0.82-2.52],0.2062301563819563
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,22198,70,1.13 [0.84-1.52],0.4235015653665555
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,22222,70,1.14 [0.91-1.42],0.2531065491354719
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,22060,66,1.11 [0.85-1.44],0.4414983420891736
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,19658,61,1.25 [0.93-1.68],0.1368501823307063
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,19152,63,0.61 [0.37-1.00],0.0499680835340375
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,19591,60,1.15 [0.62-2.15],0.6503982666902908
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,19206,60,0.97 [0.61-1.55],0.9109346039757242
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,22797,71,1.16 [0.85-1.60],0.3427385269849917
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,21456,66,1.45 [0.84-2.50],0.1799888598120779
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22408,65,1.04 [0.61-1.79],0.8746694632602086
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22662,72,1.37 [0.76-2.48],0.2951030192924923
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,22825,71,1.40 [0.77-2.55],0.2767397533234893
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,22198,70,1.46 [0.76-2.79],0.2576834599429328
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22470,65,0.95 [0.63-1.42],0.7949939760838811
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,22825,71,1.28 [0.94-1.73],0.1138287879353115
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,22783,73,1.09 [0.55-2.17],0.7957162844399097
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,19152,63,1.25 [0.83-1.88],0.2781899225280363
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,22695,72,1.05 [0.83-1.33],0.683251278004208
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,22060,66,0.91 [0.49-1.67],0.756717473190184
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,19658,61,3.08 [1.50-6.33],0.0021447576577635
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19597,60,1.07 [0.90-1.27],0.4568378100264726
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,22521,70,1.11 [0.92-1.34],0.254063943950126
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,19591,60,0.95 [0.44-2.04],0.8861323011592533
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,19099,60,1.05 [0.72-1.55],0.7937271951580187
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,22198,70,0.98 [0.76-1.26],0.8801831064071973
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,19288,62,1.24 [0.89-1.71],0.1999339411905381
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,19152,63,0.95 [0.40-2.26],0.8989642528377821
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,19152,63,0.92 [0.48-1.73],0.7861893423050594
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,22112,69,1.09 [0.81-1.47],0.5751827831829021
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,22222,70,1.25 [0.80-1.95],0.3271829223806262
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,19099,60,0.88 [0.56-1.37],0.5576106187156509
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,19597,60,0.93 [0.71-1.22],0.5938220899232809
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,19658,61,1.30 [0.74-2.25],0.3592715283949417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,19152,63,1.37 [0.87-2.16],0.1774927101654164
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,19320,61,1.15 [0.81-1.63],0.4305014252170205
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,19591,60,0.83 [0.58-1.19],0.3071957292502417
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,19597,60,1.08 [0.76-1.54],0.6588123534340772
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19591,60,0.88 [0.55-1.41],0.5985966493315608
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,19200,61,1.03 [0.94-1.14],0.5106273479178478
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,19005,60,0.68 [0.27-1.70],0.4126482734063383
Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,19090,59,1.00 [0.77-1.29],0.976913268829348
